site aa pred_sec pred_expbur pred_accessibility pdb_asym_id hetero nucleotide compound metal otherpoly homo precipitant A C D E F G H I K L M N P Q R S T V W Y feature_table variant 1 M 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 2 V 64 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 36 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 3 D 0 0 18 0 0 0 0 0 0 0 0 0 82 0 0 0 0 0 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 4 G 0 0 0 0 0 55 0 0 0 0 0 0 0 0 45 0 0 0 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 5 T 0 0 0 0 0 0 0 0 0 0 17 0 20 0 0 7 56 0 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 6 L 0 0 0 0 20 0 0 0 0 61 0 0 0 0 0 0 0 19 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 7 L 0 0 0 0 32 0 0 8 0 56 0 0 0 0 0 0 0 4 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 8 L 0 0 0 0 0 0 0 9 0 84 0 0 8 0 0 0 0 0 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 9 L 0 0 0 0 8 0 0 13 0 65 0 0 15 0 0 0 0 0 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 10 L 0 0 0 0 5 0 0 0 0 95 0 0 0 0 0 0 0 0 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 11 S 20 0 0 14 0 0 0 13 0 10 0 0 0 0 0 36 7 0 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 12 E 11 0 0 10 0 36 0 13 14 0 0 0 0 0 10 0 0 7 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 13 A 36 0 0 0 7 0 0 13 0 0 0 0 14 0 0 7 10 13 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 14 L 0 0 0 0 13 0 0 0 0 56 0 0 0 7 14 0 0 10 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 15 A 56 0 0 0 0 6 0 0 0 0 11 0 11 0 0 3 3 11 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 16 L 9 0 0 0 26 0 0 0 0 26 6 0 0 6 0 0 16 9 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 17 T 8 0 0 0 0 0 0 0 12 13 0 0 0 6 0 0 53 9 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 18 Q 0 0 1 24 0 5 2 0 0 3 0 0 10 53 1 0 0 0 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 19 T 5 0 0 6 0 0 0 0 0 0 0 0 7 0 5 8 59 10 0 0 SIGNAL::SIGNAL: 20 W 0 3 3 0 0 7 3 0 0 1 0 2 5 10 13 0 0 11 43 0 SIGNAL::SIGNAL: 21 A 64 0 0 0 0 12 0 0 0 0 0 0 6 0 0 4 2 10 0 0 SIGNAL::SIGNAL: 22 G e 79.8 7p4b_C 8 1 11 3 0 60 0 0 0 0 0 0 0 7 9 1 0 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 23 S e 53.1 7p4b_C EDO 8 0 0 3 0 0 0 0 0 0 8 2 19 1 2 44 12 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 24 H E b 17.8 7p4b_C 0 0 0 9 0 0 78 0 0 0 0 0 3 0 3 0 0 0 0 8 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 25 S E b 11.7 7p4b_C 6 0 0 0 0 0 0 0 0 0 0 0 3 0 0 67 15 8 0 2 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 26 L E b 1.1 7p4b_C INHA_MYCTU:Peptide VMAPRTVLL[9 aa]:Peptide VTAPRTLLL[9 aa]:VMAPRTLIL peptide from CMV gpUL40[9 aa]:leader peptide of HLA class I histocompatibility a..:Mtb44*P2-Phe peptide variant (ARG-PHE-PRO-ALA-LYS-..:Enoyl-[acyl-carrier-protein] reductase [NADH][9 aa..:Enoyl-[acyl-carrier-protein] reductase [NADH][12 a..:UL40(15-23 H4C)[9 aa] 0 0 0 0 0 0 0 0 0 81 13 0 0 6 0 0 0 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 27 K E e 26.4 7p4b_C B2MG_HUMAN:Beta-2-microglobulin[100 aa] EDO:GOL 0 6 0 0 0 0 2 2 2 5 5 0 0 7 62 2 4 0 4 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 28 Y E b 6.5 7p4b_C Q0QI92_HCMV:HLAG_HUMAN:1C07_HUMAN:INHA_MYCTU:B6S6I4_9HIV1:PPSB_MYCTU:ESXH_MYCTU:Peptide VMAPRTVLL[9 aa]:Peptide VTAPRTLLL[9 aa]:PEPTIDE (VMAPRTVLL)[9 aa]:VMAPRTLIL peptide from CMV gpUL40[9 aa]:Peptide from Glycoprotein[9 aa]:leader peptide of HLA class I histocompatibility a..:HLA class I histocompatibility antigen peptide[9 a..:Mtb44*P2-Phe peptide variant (ARG-PHE-PRO-ALA-LYS-..:Enoyl-[acyl-carrier-protein] reductase [NADH][9 aa..:ARG-GLN-PRO-ALA-LYS-ALA-PRO-LEU-LEU[9 aa]:ARG-LEU-PRO-ALA-LYS-ALA-PRO-LEU-PHE[9 aa]:ARG-MET-TYR-SER-PRO-THR-SER-ILE-LEU[9 aa]:Enoyl-[acyl-carrier-protein] reductase [NADH][12 a..:VL9 leader peptide[9 aa]:Gag6V[9 aa]:UL40(15-23 H4C)[9 aa]:Gag6V(276-284 H4C)[9 aa]:Phenolphthiocerol/phthiocerol polyketide synthase ..:ESAT-6-like protein EsxH[9 aa]:Peptide from inhA[9 aa] 0 0 0 0 5 0 0 0 6 0 0 0 0 0 0 0 0 0 0 89 BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" ECO:0000269|PubMed:35705051, ECO:0007744|PDB:7P4B":TOPO_DOM:/note="Extracellular":BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" ECO:0000269|PubMed:35705051, ECO:0007744|PDB:7P4B":TOPO_DOM:/note="Extracellular" 29 F E e 32.1 7p4b_C B2MG_HUMAN:BETA-2-MICROGLOBULIN[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[97 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[99 aa] EDO:GOL 0 0 14 0 34 8 10 5 0 12 0 18 0 0 0 0 0 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 30 H E b 7.9 7p4b_C B2MG_HUMAN:Q0QI92_HCMV:HLAG_HUMAN:1C07_HUMAN:INHA_MYCTU:B6S6I4_9HIV1:PPSB_MYCTU:ESXH_MYCTU:BETA-2-MICROGLOBULIN[100 aa]:Peptide VMAPRTVLL[9 aa]:Peptide VTAPRTLLL[9 aa]:PEPTIDE (VMAPRTVLL)[9 aa]:Beta-2-microglobulin[100 aa]:VMAPRTLIL peptide from CMV gpUL40[9 aa]:Peptide from Glycoprotein[9 aa]:leader peptide of HLA class I histocompatibility a..:Beta-2-microglobulin[97 aa]:HLA class I histocompatibility antigen peptide[9 a..:Mtb44*P2-Phe peptide variant (ARG-PHE-PRO-ALA-LYS-..:Enoyl-[acyl-carrier-protein] reductase [NADH][9 aa..:ARG-GLN-PRO-ALA-LYS-ALA-PRO-LEU-LEU[9 aa]:ARG-LEU-PRO-ALA-LYS-ALA-PRO-LEU-PHE[9 aa]:ARG-MET-TYR-SER-PRO-THR-SER-ILE-LEU[9 aa]:Enoyl-[acyl-carrier-protein] reductase [NADH][12 a..:VL9 leader peptide[9 aa]:Beta-2-microglobulin[98 aa]:Gag6V[9 aa]:Beta-2-microglobulin[99 aa]:UL40(15-23 H4C)[9 aa]:Gag6V(276-284 H4C)[9 aa]:Phenolphthiocerol/phthiocerol polyketide synthase ..:ESAT-6-like protein EsxH[9 aa]:Peptide from inhA[9 aa] 0 0 2 2 14 0 6 6 0 18 0 0 0 2 5 6 1 7 0 29 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 31 T E e 31.8 7p4b_C B2MG_HUMAN:BETA-2-MICROGLOBULIN[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[97 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[99 aa] 3 0 0 0 0 0 0 0 0 5 15 0 0 0 3 0 74 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 32 S E b 1.6 7p4b_C 42 0 0 0 0 25 0 4 0 0 6 0 0 0 0 8 2 12 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 33 V E e 28.7 7p4b_C B2MG_HUMAN:BETA-2-MICROGLOBULIN[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[97 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[99 aa] EDO 7 3 0 0 0 0 3 20 0 20 4 0 0 0 0 6 0 37 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 34 S b 17.2 7p4b_C EDO 1 0 0 0 3 1 4 0 0 1 0 0 6 0 0 78 3 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 35 R e 21.7 7p4b_C SO4:EDO 0 0 8 7 15 0 0 0 5 14 0 5 1 3 36 2 0 0 4 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 36 P T e 27.1 7p4b_C 8 0 13 8 0 0 2 0 3 2 0 0 61 2 2 0 0 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 37 G T e 109.5 7p4b_C B2MG_HUMAN:BETA-2-MICROGLOBULIN[100 aa] 7 0 14 0 0 50 0 1 0 3 0 8 0 0 6 8 0 5 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 38 R S e 60.9 7p4b_C B2MG_HUMAN:BETA-2-MICROGLOBULIN[100 aa]:Beta-2-microglobulin[100 aa] SO4:EDO 2 0 0 4 1 0 5 2 3 16 0 0 13 0 23 14 12 0 0 2 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 39 G S e 72.6 7p4b_C B2MG_HUMAN:BETA-2-MICROGLOBULIN[100 aa] 0 0 2 9 0 59 0 0 0 1 0 0 0 0 1 17 0 8 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 40 E S e 37.7 7p4b_C KLRD1_HUMAN:Natural killer cells antigen CD94[123 aa]:Natural killer cells antigen CD94[121 aa]:GF4 T cell receptor beta chain[243 aa] HLAE_HUMAN:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, ALPHA CHAI..:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN HLA-E[273 a.. 0 0 1 26 4 0 8 2 4 19 0 0 0 15 0 0 5 6 8 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 41 P b 7.8 7p4b_C 0 0 0 0 0 0 0 0 0 0 8 0 69 4 0 15 5 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 42 R E e 32.4 7p4b_C B2MG_HUMAN:Beta-2-microglobulin[100 aa] SO4:EDO 7 0 0 5 2 6 0 0 0 5 0 0 0 8 45 6 8 0 9 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 43 F E b 0.5 7p4b_C 0 4 0 0 60 0 0 0 0 13 0 0 0 0 0 0 8 3 6 8 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 44 I E e 31.6 7p4b_C B2MG_HUMAN:BETA-2-MICROGLOBULIN[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[97 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[99 aa] EDO 0 6 8 10 0 0 0 32 0 17 2 0 0 7 0 3 8 2 7 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 45 S E b 1.6 7p4b_C 1C07_HUMAN:PPSB_MYCTU:leader peptide of HLA class I histocompatibility a..:Mtb44*P2-Phe peptide variant (ARG-PHE-PRO-ALA-LYS-..:Phenolphthiocerol/phthiocerol polyketide synthase .. 36 0 0 3 0 0 0 6 0 3 0 0 0 0 0 25 9 18 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 46 V E b 19.3 7p4b_C B2MG_HUMAN:BETA-2-MICROGLOBULIN[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[97 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[99 aa] 2 0 0 6 0 0 0 0 0 17 1 0 0 4 2 5 8 54 3 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 47 G E b 0.0 7p4b_C 4 0 0 1 0 74 0 6 0 0 0 0 0 0 4 3 0 6 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 48 Y E e 33.5 7p4b_C B2MG_HUMAN:BETA-2-MICROGLOBULIN[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[97 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[99 aa] EDO:GOL 0 0 0 0 3 0 5 6 0 2 0 0 0 8 0 2 0 0 28 46 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 49 V E b 0.0 7p4b_C 0 0 0 0 11 0 0 0 0 42 0 0 0 0 0 0 0 47 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 50 D T b 16.0 7p4b_C EDO:GOL 0 0 73 0 0 19 0 0 0 0 0 6 0 0 0 3 0 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 51 D T e 42.0 7p4b_C EDO:GOL 2 0 58 7 0 13 0 0 0 0 0 7 6 3 0 4 0 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 52 T E e 20.1 7p4b_C GOL 0 0 0 12 0 0 4 0 8 22 2 0 0 27 0 0 24 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 53 Q E e 24.5 7p4b_C B2MG_HUMAN:BETA-2-MICROGLOBULIN[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[97 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[99 aa] 3 0 0 6 0 0 6 0 0 11 0 3 15 51 0 0 5 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 54 F E b 0.0 7p4b_C 0 0 0 0 65 0 0 13 0 5 0 0 0 0 0 0 9 0 0 8 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 55 V E b 1.3 7p4b_C 0 0 0 0 12 2 18 0 0 30 0 0 0 0 0 0 4 31 0 2 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 56 R E e 33.2 7p4b_C B2MG_HUMAN:BETA-2-MICROGLOBULIN[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[97 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[99 aa] EDO 1 0 0 0 1 11 13 0 2 0 1 0 2 1 38 12 16 0 1 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 57 F E b 0.5 7p4b_C 0 2 0 0 27 0 0 0 0 0 2 0 0 0 0 0 0 0 18 51 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 58 D E e 20.4 7p4b_C EDO 0 0 54 3 0 0 0 0 2 0 0 28 0 0 0 13 0 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 59 N b 6.1 7p4b_C 1 0 1 1 1 5 6 1 1 1 0 15 1 1 6 55 3 1 0 1 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 60 D e 54.9 7p4b_C ACT 1 0 55 11 1 1 0 1 1 6 0 6 1 5 1 5 3 1 0 1 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 61 A S e 53.6 7p4b_C 24 8 2 1 0 7 0 0 12 1 0 0 3 0 7 32 3 1 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 62 A S e 101.8 7p4b_C HLAE_HUMAN:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, ALPHA CHAI.. 27 2 3 10 0 25 0 3 5 4 0 0 1 0 8 3 0 5 2 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 63 S S e 63.3 7p4b_C SO4 1 1 2 5 0 1 0 2 1 1 0 12 1 1 4 37 30 1 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 64 P b 15.5 7p4b_C HLAE_HUMAN:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, ALPHA CHAI.. 16 0 9 1 1 2 0 7 6 2 0 1 23 8 11 8 4 1 0 1 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 65 R e 35.2 7p4b_C HLAE_HUMAN:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, ALPHA CHAI.. SO4:EDO 0 0 0 7 0 0 0 14 9 2 0 0 0 5 45 9 7 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 66 M E b 5.3 7p4b_C Q0QI92_HCMV:HLAG_HUMAN:1C07_HUMAN:INHA_MYCTU:PPSB_MYCTU:ESXH_MYCTU:Peptide VMAPRTVLL[9 aa]:Peptide VTAPRTLLL[9 aa]:PEPTIDE (VMAPRTVLL)[9 aa]:Peptide from Glycoprotein[9 aa]:leader peptide of HLA class I histocompatibility a..:VMAPRTLIL peptide from CMV gpUL40[9 aa]:Mtb44*P2-Phe peptide variant (ARG-PHE-PRO-ALA-LYS-..:Enoyl-[acyl-carrier-protein] reductase [NADH][9 aa..:ARG-GLN-PRO-ALA-LYS-ALA-PRO-LEU-LEU[9 aa]:ARG-LEU-PRO-ALA-LYS-ALA-PRO-LEU-PHE[9 aa]:ARG-MET-TYR-SER-PRO-THR-SER-ILE-LEU[9 aa]:Enoyl-[acyl-carrier-protein] reductase [NADH][12 a..:VL9 leader peptide[9 aa]:Gag6V(276-284 H4C)[9 aa]:Phenolphthiocerol/phthiocerol polyketide synthase ..:ESAT-6-like protein EsxH[9 aa]:Peptide from inhA[9 aa] EDO 24 0 1 3 18 2 0 7 5 0 14 0 0 2 0 2 2 12 0 7 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 67 V E e 27.3 7p4b_C EDO 0 0 4 41 0 0 0 5 7 14 0 7 0 2 0 0 12 6 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 68 P E e 35.7 7p4b_C HLAE_HUMAN:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, ALPHA CHAI.. 1 0 1 1 5 8 0 1 1 3 0 1 62 2 1 5 1 1 0 4 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 69 R e 49.0 7p4b_C B2MG_HUMAN:BETA-2-MICROGLOBULIN[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[97 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[99 aa] HLAE_HUMAN:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, ALPHA CHAI.. GOL 1 6 1 1 1 1 0 1 6 7 5 1 1 6 39 3 8 8 2 3 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 70 A S b 3.6 7p4b_C HLAE_HUMAN:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, ALPHA CHAI.. 32 3 0 3 0 19 0 9 19 0 0 0 0 3 2 5 4 2 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 71 P G e 74.4 7p4b_C 7 4 0 2 0 0 5 0 2 3 0 0 56 7 7 7 0 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 72 W G b 8.8 7p4b_C 0 0 0 0 0 0 0 0 0 8 0 0 0 0 0 0 0 0 90 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 73 M G b 0.0 7p4b_C 5 0 0 3 0 5 0 13 0 3 24 0 0 0 3 28 0 15 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 74 E T e 68.8 7p4b_C HLAE_HUMAN:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, ALPHA CHAI.. 10 0 2 44 0 2 1 0 25 1 0 0 0 10 3 1 0 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 75 Q T e 63.8 7p4b_C 4 0 2 2 0 21 4 0 6 0 2 17 0 28 3 4 0 5 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 76 E b 15.1 7p4b_C 0 0 0 29 0 3 2 0 8 10 0 15 0 8 2 0 5 14 0 3 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 77 G e 52.4 7p4b_C 11 0 0 4 16 36 0 0 0 5 0 5 0 0 2 11 0 8 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 78 S H e 64.1 7p4b_C 3H4 Fab heavy chain[225 aa]:3H4 Fab heavy chain[218 aa] HLAE_HUMAN:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, ALPHA CHAI.. 11 0 4 0 0 6 0 0 0 0 5 2 28 0 1 34 8 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 79 E H e 84.4 7p4b_C 3H4 Fab heavy chain[225 aa]:3H4 Fab light chain[214 aa]:3H4 Fab heavy chain[218 aa] 4 0 10 35 0 1 0 1 6 1 0 7 1 11 4 1 9 1 8 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 80 Y H b 6.5 7p4b_C Q0QI92_HCMV:HLAG_HUMAN:1C07_HUMAN:INHA_MYCTU:B6S6I4_9HIV1:ESXH_MYCTU:Peptide VMAPRTVLL[9 aa]:Peptide VTAPRTLLL[9 aa]:PEPTIDE (VMAPRTVLL)[9 aa]:VMAPRTLIL peptide from CMV gpUL40[9 aa]:Peptide from Glycoprotein[9 aa]:leader peptide of HLA class I histocompatibility a..:Mtb44*P2-Phe peptide variant (ARG-PHE-PRO-ALA-LYS-..:Enoyl-[acyl-carrier-protein] reductase [NADH][9 aa..:ARG-GLN-PRO-ALA-LYS-ALA-PRO-LEU-LEU[9 aa]:ARG-MET-TYR-SER-PRO-THR-SER-ILE-LEU[9 aa]:Enoyl-[acyl-carrier-protein] reductase [NADH][12 a..:VL9 leader peptide[9 aa]:Gag6V[9 aa]:ESAT-6-like protein EsxH[9 aa] 9 0 6 4 5 1 5 1 1 6 2 1 1 3 1 1 10 1 0 41 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 81 W H b 11.2 7p4b_C HLAE_HUMAN:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, ALPHA CHAI.. EDO 1 3 1 1 1 1 0 1 1 5 0 1 4 1 1 6 1 1 70 1 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 82 D H e 29.0 7p4b_C 3H4 Fab heavy chain[225 aa]:3H4 Fab heavy chain[218 aa] 4 0 31 29 0 5 0 1 7 6 0 6 1 0 1 1 6 1 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 83 R H e 57.7 7p4b_C Q0QI92_HCMV:HLAG_HUMAN:INHA_MYCTU:B6S6I4_9HIV1:TVA4_HUMAN:A0A075B6U7_HUMAN:TRAR1_HUMAN:PPSB_MYCTU:ESXH_MYCTU:Peptide from Glycoprotein[9 aa]:leader peptide of HLA class I histocompatibility a..:VMAPRTLIL peptide from CMV gpUL40[9 aa]:Mtb44*P2-Phe peptide variant (ARG-PHE-PRO-ALA-LYS-..:Enoyl-[acyl-carrier-protein] reductase [NADH][9 aa..:ARG-GLN-PRO-ALA-LYS-ALA-PRO-LEU-LEU[9 aa]:ARG-LEU-PRO-ALA-LYS-ALA-PRO-LEU-PHE[9 aa]:ARG-MET-TYR-SER-PRO-THR-SER-ILE-LEU[9 aa]:Enoyl-[acyl-carrier-protein] reductase [NADH][12 a..:T-cell receptor alpha chain[190 aa]:T-cell receptor alpha chain[189 aa]:3H4 Fab heavy chain[225 aa]:3H4 Fab light chain[214 aa]:VL9 leader peptide[9 aa]:3H4 Fab heavy chain[218 aa]:Gag6V[9 aa]:UL40(15-23 H4C)[9 aa]:Gag6V(276-284 H4C)[9 aa]:T cell receptor alpha variable 4,T cell receptor a..:Phenolphthiocerol/phthiocerol polyketide synthase ..:ESAT-6-like protein EsxH[9 aa]:Peptide from inhA[9 aa]:T-cell receptor alpha chain[187 aa] HLAE_HUMAN:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, ALPHA CHAI.. SO4 5 0 0 13 0 6 1 0 18 1 0 0 0 13 30 1 3 1 1 4 MUTAGEN:/note="R->A: Has no impact on the affinity for KLRD1- KLRC1.":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="R->A: Has no impact on the affinity for KLRD1- KLRC1.":TOPO_DOM:/note="Extracellular" 84 E H b 16.6 7p4b_C Q0QI92_HCMV:HLAG_HUMAN:1C07_HUMAN:INHA_MYCTU:B6S6I4_9HIV1:PPSB_MYCTU:ESXH_MYCTU:Peptide VMAPRTVLL[9 aa]:Peptide VTAPRTLLL[9 aa]:PEPTIDE (VMAPRTVLL)[9 aa]:VMAPRTLIL peptide from CMV gpUL40[9 aa]:Peptide from Glycoprotein[9 aa]:leader peptide of HLA class I histocompatibility a..:HLA class I histocompatibility antigen peptide[9 a..:Mtb44*P2-Phe peptide variant (ARG-PHE-PRO-ALA-LYS-..:Enoyl-[acyl-carrier-protein] reductase [NADH][9 aa..:ARG-GLN-PRO-ALA-LYS-ALA-PRO-LEU-LEU[9 aa]:ARG-LEU-PRO-ALA-LYS-ALA-PRO-LEU-PHE[9 aa]:ARG-MET-TYR-SER-PRO-THR-SER-ILE-LEU[9 aa]:Enoyl-[acyl-carrier-protein] reductase [NADH][12 a..:3H4 Fab heavy chain[225 aa]:VL9 leader peptide[9 aa]:3H4 Fab heavy chain[218 aa]:Gag6V[9 aa]:UL40(15-23 H4C)[9 aa]:Gag6V(276-284 H4C)[9 aa]:Phenolphthiocerol/phthiocerol polyketide synthase ..:ESAT-6-like protein EsxH[9 aa]:Peptide from inhA[9 aa] 1 0 5 49 0 0 0 1 0 11 0 4 0 20 0 0 2 0 0 4 BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" ECO:0007744|PDB:7P49, ECO:0007744|PDB:7P4B":TOPO_DOM:/note="Extracellular":BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" ECO:0007744|PDB:7P49, ECO:0007744|PDB:7P4B":TOPO_DOM:/note="Extracellular" 85 T H b 0.0 7p4b_C 3 0 4 0 0 1 0 3 0 6 0 7 0 2 0 9 49 7 7 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 86 R H e 62.5 7p4b_C TCB_HUMAN:KLRD1_HUMAN:NKG2A_HUMAN:TVB79_HUMAN:TJB12_HUMAN:K7N5M4_HUMAN:TVB14_HUMAN:TJB23_HUMAN:TRBC2_HUMAN:TVA4_HUMAN:A0A075B6U7_HUMAN:TRAR1_HUMAN:KK50.4 T cell receptor beta chain[240 aa]:Natural killer cells antigen CD94[123 aa]:NKG2-A/NKG2-B type II integral membrane protein[11..:NKG2-A/NKG2-B type II integral membrane protein[12..:Natural killer cells antigen CD94[121 aa]:GF4 T cell receptor beta chain[243 aa]:GF4 T cell receptor alpha chain[201 aa]:GF4 T cell receptor alpha chain[199 aa]:GF4 T cell receptor alpha chain[202 aa]:T-cell receptor beta chain[245 aa]:T-cell receptor beta chain[243 aa]:3H4 Fab heavy chain[225 aa]:3H4 Fab heavy chain[218 aa]:T cell receptor beta variable 7-9,M1-specific T ce..:T cell receptor beta variable 14,T cell receptor b..:T cell receptor alpha variable 4,T cell receptor a..:T cell receptor beta variable 7-9,T cell receptor ..:T-cell receptor alpha chain[187 aa]:T-cell receptor beta chain[241 aa] HLAE_HUMAN:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, ALPHA CHAI..:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN HLA-E[273 a.. SO4 4 0 2 19 0 5 2 0 2 3 3 0 5 27 13 0 12 0 1 0 MUTAGEN:/note="R->A: Reduces the affinity for KLRD1-KLRC1.":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="R->A: Reduces the affinity for KLRD1-KLRC1.":TOPO_DOM:/note="Extracellular" 87 S H e 43.8 7p4b_C Q0QI92_HCMV:HLAG_HUMAN:1C07_HUMAN:INHA_MYCTU:B6S6I4_9HIV1:PPSB_MYCTU:ESXH_MYCTU:Peptide VMAPRTVLL[9 aa]:Peptide VTAPRTLLL[9 aa]:PEPTIDE (VMAPRTVLL)[9 aa]:VMAPRTLIL peptide from CMV gpUL40[9 aa]:Peptide from Glycoprotein[9 aa]:leader peptide of HLA class I histocompatibility a..:Mtb44*P2-Phe peptide variant (ARG-PHE-PRO-ALA-LYS-..:Enoyl-[acyl-carrier-protein] reductase [NADH][9 aa..:ARG-GLN-PRO-ALA-LYS-ALA-PRO-LEU-LEU[9 aa]:ARG-LEU-PRO-ALA-LYS-ALA-PRO-LEU-PHE[9 aa]:ARG-MET-TYR-SER-PRO-THR-SER-ILE-LEU[9 aa]:Enoyl-[acyl-carrier-protein] reductase [NADH][12 a..:VL9 leader peptide[9 aa]:Gag6V[9 aa]:UL40(15-23 H4C)[9 aa]:Gag6V(276-284 H4C)[9 aa]:Phenolphthiocerol/phthiocerol polyketide synthase ..:ESAT-6-like protein EsxH[9 aa]:Peptide from inhA[9 aa] 3 2 16 17 0 0 0 11 9 9 5 5 0 3 3 8 1 6 0 1 BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" ECO:0007744|PDB:7P4B":TOPO_DOM:/note="Extracellular":BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" ECO:0007744|PDB:7P4B":TOPO_DOM:/note="Extracellular" 88 A H b 4.5 7p4b_C Q0QI92_HCMV:HLAG_HUMAN:1C07_HUMAN:INHA_MYCTU:B6S6I4_9HIV1:PPSB_MYCTU:ESXH_MYCTU:Peptide VMAPRTVLL[9 aa]:PEPTIDE (VMAPRTVLL)[9 aa]:VMAPRTLIL peptide from CMV gpUL40[9 aa]:Peptide from Glycoprotein[9 aa]:leader peptide of HLA class I histocompatibility a..:HLA class I histocompatibility antigen peptide[9 a..:Mtb44*P2-Phe peptide variant (ARG-PHE-PRO-ALA-LYS-..:Enoyl-[acyl-carrier-protein] reductase [NADH][9 aa..:ARG-GLN-PRO-ALA-LYS-ALA-PRO-LEU-LEU[9 aa]:ARG-LEU-PRO-ALA-LYS-ALA-PRO-LEU-PHE[9 aa]:ARG-MET-TYR-SER-PRO-THR-SER-ILE-LEU[9 aa]:Enoyl-[acyl-carrier-protein] reductase [NADH][12 a..:VL9 leader peptide[9 aa]:Gag6V[9 aa]:UL40(15-23 H4C)[9 aa]:Phenolphthiocerol/phthiocerol polyketide synthase ..:ESAT-6-like protein EsxH[9 aa]:Peptide from inhA[9 aa] 15 1 0 0 2 3 0 1 3 47 3 0 0 5 4 6 1 5 0 4 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 89 R H e 33.6 7p4b_C TVB79_HUMAN:TJB12_HUMAN:K7N5M4_HUMAN:GF4 T cell receptor beta chain[243 aa]:T-cell receptor beta chain[245 aa]:T cell receptor beta variable 7-9,M1-specific T ce..:T cell receptor beta variable 7-9,T cell receptor ..:T-cell receptor beta chain[241 aa] SO4 6 0 0 7 0 3 0 0 33 0 0 0 2 14 23 2 6 2 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 90 D H e 64.2 7p4b_C TCA_HUMAN:TCB_HUMAN:Q0QI92_HCMV:KLRD1_HUMAN:B6S6I4_9HIV1:TVB79_HUMAN:TJB12_HUMAN:K7N5M4_HUMAN:TVB14_HUMAN:TJB23_HUMAN:TRBC2_HUMAN:Peptide VMAPRTVLL[9 aa]:Peptide VTAPRTLLL[9 aa]:PEPTIDE (VMAPRTVLL)[9 aa]:KK50.4 T cell receptor alpha chain[199 aa]:KK50.4 T cell receptor beta chain[240 aa]:Peptide from Glycoprotein[9 aa]:Natural killer cells antigen CD94[123 aa]:Natural killer cells antigen CD94[121 aa]:GF4 T cell receptor alpha chain[201 aa]:GF4 T cell receptor beta chain[243 aa]:GF4 T cell receptor alpha chain[202 aa]:GF4 T cell receptor alpha chain[199 aa]:ARG-MET-TYR-SER-PRO-THR-SER-ILE-LEU[9 aa]:T-cell receptor alpha chain[188 aa]:T-cell receptor beta chain[243 aa]:T-cell receptor alpha chain[190 aa]:T-cell receptor beta chain[245 aa]:T-cell receptor alpha chain[189 aa]:3H4 Fab heavy chain[225 aa]:3H4 Fab heavy chain[218 aa]:Gag6V[9 aa]:T cell receptor beta variable 7-9,M1-specific T ce..:T cell receptor beta variable 14,T cell receptor b..:Gag6V(276-284 H4C)[9 aa]:T cell receptor beta variable 7-9,T cell receptor ..:T-cell receptor beta chain[241 aa] HLAE_HUMAN:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, ALPHA CHAI..:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN HLA-E[273 a.. 13 0 12 29 0 19 9 2 5 0 0 0 0 0 2 5 1 2 0 0 MUTAGEN:/note="D->A: Has no impact on the affinity for KLRD1- KLRC1.":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="D->A: Has no impact on the affinity for KLRD1- KLRC1.":TOPO_DOM:/note="Extracellular" 91 T H b 16.9 7p4b_C Q0QI92_HCMV:HLAG_HUMAN:1C07_HUMAN:INHA_MYCTU:B6S6I4_9HIV1:PPSB_MYCTU:ESXH_MYCTU:Peptide VMAPRTVLL[9 aa]:Peptide VTAPRTLLL[9 aa]:PEPTIDE (VMAPRTVLL)[9 aa]:VMAPRTLIL peptide from CMV gpUL40[9 aa]:Peptide from Glycoprotein[9 aa]:leader peptide of HLA class I histocompatibility a..:HLA class I histocompatibility antigen peptide[9 a..:Mtb44*P2-Phe peptide variant (ARG-PHE-PRO-ALA-LYS-..:Enoyl-[acyl-carrier-protein] reductase [NADH][9 aa..:ARG-GLN-PRO-ALA-LYS-ALA-PRO-LEU-LEU[9 aa]:ARG-LEU-PRO-ALA-LYS-ALA-PRO-LEU-PHE[9 aa]:ARG-MET-TYR-SER-PRO-THR-SER-ILE-LEU[9 aa]:Enoyl-[acyl-carrier-protein] reductase [NADH][12 a..:VL9 leader peptide[9 aa]:Gag6V[9 aa]:UL40(15-23 H4C)[9 aa]:Gag6V(276-284 H4C)[9 aa]:Phenolphthiocerol/phthiocerol polyketide synthase ..:ESAT-6-like protein EsxH[9 aa]:Peptide from inhA[9 aa] 0 0 1 4 0 3 4 3 8 16 7 15 0 5 5 2 7 10 9 2 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 92 A H b 8.0 7p4b_C 15 0 8 32 13 9 0 0 0 3 0 2 0 4 2 1 1 9 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 93 Q H e 44.4 7p4b_C TCB_HUMAN:KLRD1_HUMAN:TVB79_HUMAN:TJB12_HUMAN:K7N5M4_HUMAN:TVB14_HUMAN:TJB23_HUMAN:TRBC2_HUMAN:KK50.4 T cell receptor beta chain[240 aa]:Natural killer cells antigen CD94[123 aa]:Natural killer cells antigen CD94[121 aa]:GF4 T cell receptor beta chain[243 aa]:T-cell receptor beta chain[243 aa]:T-cell receptor beta chain[245 aa]:T-cell receptor beta chain[244 aa]:T cell receptor beta variable 7-9,M1-specific T ce..:T cell receptor beta variable 14,T cell receptor b..:T cell receptor beta variable 7-9,T cell receptor ..:T-cell receptor beta chain[241 aa] HLAE_HUMAN:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, ALPHA CHAI..:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN HLA-E[273 a.. 0 0 8 14 0 0 2 0 6 4 0 2 0 44 11 0 5 0 0 3 MUTAGEN:/note="Q->A: Impairs the recognition by KLRD1-KLRC1.":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="Q->A: Impairs the recognition by KLRD1-KLRC1.":TOPO_DOM:/note="Extracellular" 94 I H e 52.0 7p4b_C TCB_HUMAN:Q0QI92_HCMV:HLAG_HUMAN:1C07_HUMAN:KLRD1_HUMAN:INHA_MYCTU:B6S6I4_9HIV1:TVB79_HUMAN:TJB12_HUMAN:K7N5M4_HUMAN:TVB14_HUMAN:TJB23_HUMAN:TRBC2_HUMAN:PPSB_MYCTU:ESXH_MYCTU:Peptide VMAPRTVLL[9 aa]:Peptide VTAPRTLLL[9 aa]:PEPTIDE (VMAPRTVLL)[9 aa]:VMAPRTLIL peptide from CMV gpUL40[9 aa]:KK50.4 T cell receptor beta chain[240 aa]:Peptide from Glycoprotein[9 aa]:leader peptide of HLA class I histocompatibility a..:Natural killer cells antigen CD94[123 aa]:HLA class I histocompatibility antigen peptide[9 a..:Natural killer cells antigen CD94[121 aa]:GF4 T cell receptor alpha chain[201 aa]:GF4 T cell receptor beta chain[243 aa]:GF4 T cell receptor alpha chain[202 aa]:GF4 T cell receptor alpha chain[199 aa]:Mtb44*P2-Phe peptide variant (ARG-PHE-PRO-ALA-LYS-..:Enoyl-[acyl-carrier-protein] reductase [NADH][9 aa..:ARG-GLN-PRO-ALA-LYS-ALA-PRO-LEU-LEU[9 aa]:ARG-LEU-PRO-ALA-LYS-ALA-PRO-LEU-PHE[9 aa]:ARG-MET-TYR-SER-PRO-THR-SER-ILE-LEU[9 aa]:T-cell receptor alpha chain[188 aa]:T-cell receptor beta chain[243 aa]:Enoyl-[acyl-carrier-protein] reductase [NADH][12 a..:T-cell receptor alpha chain[190 aa]:T-cell receptor beta chain[245 aa]:T-cell receptor beta chain[244 aa]:T-cell receptor alpha chain[189 aa]:VL9 leader peptide[9 aa]:Gag6V[9 aa]:T cell receptor beta variable 7-9,M1-specific T ce..:UL40(15-23 H4C)[9 aa]:T cell receptor beta variable 14,T cell receptor b..:Gag6V(276-284 H4C)[9 aa]:T cell receptor beta variable 7-9,T cell receptor ..:Phenolphthiocerol/phthiocerol polyketide synthase ..:ESAT-6-like protein EsxH[9 aa]:Peptide from inhA[9 aa]:T-cell receptor beta chain[241 aa] HLAE_HUMAN:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, ALPHA CHAI.. 2 0 5 0 1 0 0 24 0 14 9 1 0 3 5 8 13 13 1 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 95 F H b 2.4 7p4b_C Q0QI92_HCMV:HLAG_HUMAN:1C07_HUMAN:INHA_MYCTU:Peptide VMAPRTVLL[9 aa]:Peptide VTAPRTLLL[9 aa]:PEPTIDE (VMAPRTVLL)[9 aa]:VMAPRTLIL peptide from CMV gpUL40[9 aa]:Peptide from Glycoprotein[9 aa]:leader peptide of HLA class I histocompatibility a..:HLA class I histocompatibility antigen peptide[9 a..:Mtb44*P2-Phe peptide variant (ARG-PHE-PRO-ALA-LYS-..:Enoyl-[acyl-carrier-protein] reductase [NADH][9 aa..:ARG-GLN-PRO-ALA-LYS-ALA-PRO-LEU-LEU[9 aa]:ARG-LEU-PRO-ALA-LYS-ALA-PRO-LEU-PHE[9 aa]:Enoyl-[acyl-carrier-protein] reductase [NADH][12 a..:VL9 leader peptide[9 aa]:UL40(15-23 H4C)[9 aa]:Peptide from inhA[9 aa] 0 0 9 1 55 0 0 0 0 19 0 0 0 0 0 1 0 0 0 15 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 96 R H e 33.6 7p4b_C TCB_HUMAN:KLRD1_HUMAN:TVB79_HUMAN:TJB12_HUMAN:K7N5M4_HUMAN:KK50.4 T cell receptor beta chain[240 aa]:Natural killer cells antigen CD94[123 aa]:Natural killer cells antigen CD94[121 aa]:GF4 T cell receptor beta chain[243 aa]:T-cell receptor beta chain[243 aa]:T-cell receptor beta chain[245 aa]:T-cell receptor beta chain[244 aa]:T cell receptor beta variable 7-9,M1-specific T ce.. HLAE_HUMAN:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, ALPHA CHAI..:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN HLA-E[273 a.. SO4:GOL 0 0 0 0 3 0 1 4 8 15 5 6 0 1 50 0 8 0 0 0 MUTAGEN:/note="R->A: Abolishes the recognition by KLRD1-KLRC1.":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="R->A: Abolishes the recognition by KLRD1-KLRC1.":TOPO_DOM:/note="Extracellular" 97 V H e 56.0 7p4b_C TCB_HUMAN:1C07_HUMAN:KLRD1_HUMAN:HLAG_HUMAN:INHA_MYCTU:TVB14_HUMAN:TJB23_HUMAN:TRBC2_HUMAN:ESXH_MYCTU:Peptide VMAPRTVLL[9 aa]:Peptide VTAPRTLLL[9 aa]:KK50.4 T cell receptor beta chain[240 aa]:leader peptide of HLA class I histocompatibility a..:Natural killer cells antigen CD94[123 aa]:Natural killer cells antigen CD94[121 aa]:GF4 T cell receptor beta chain[243 aa]:Enoyl-[acyl-carrier-protein] reductase [NADH][9 aa..:ARG-LEU-PRO-ALA-LYS-ALA-PRO-LEU-PHE[9 aa]:T-cell receptor beta chain[243 aa]:T-cell receptor beta chain[245 aa]:T-cell receptor beta chain[244 aa]:VL9 leader peptide[9 aa]:T cell receptor beta variable 14,T cell receptor b..:ESAT-6-like protein EsxH[9 aa]:T-cell receptor beta chain[241 aa] HLAE_HUMAN:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, ALPHA CHAI..:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN HLA-E[273 a.. 1 0 0 22 0 3 0 7 0 11 3 0 0 0 4 3 1 43 0 0 MUTAGEN:/note="V->A: Impairs the recognition by KLRD1-KLRC1.":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="V->A: Impairs the recognition by KLRD1-KLRC1.":TOPO_DOM:/note="Extracellular" 98 N H e 31.5 7p4b_C Q0QI92_HCMV:HLAG_HUMAN:1C07_HUMAN:INHA_MYCTU:B6S6I4_9HIV1:PPSB_MYCTU:ESXH_MYCTU:Peptide VMAPRTVLL[9 aa]:Peptide VTAPRTLLL[9 aa]:PEPTIDE (VMAPRTVLL)[9 aa]:VMAPRTLIL peptide from CMV gpUL40[9 aa]:Peptide from Glycoprotein[9 aa]:leader peptide of HLA class I histocompatibility a..:HLA class I histocompatibility antigen peptide[9 a..:Mtb44*P2-Phe peptide variant (ARG-PHE-PRO-ALA-LYS-..:Enoyl-[acyl-carrier-protein] reductase [NADH][9 aa..:ARG-GLN-PRO-ALA-LYS-ALA-PRO-LEU-LEU[9 aa]:ARG-LEU-PRO-ALA-LYS-ALA-PRO-LEU-PHE[9 aa]:ARG-MET-TYR-SER-PRO-THR-SER-ILE-LEU[9 aa]:Enoyl-[acyl-carrier-protein] reductase [NADH][12 a..:VL9 leader peptide[9 aa]:Gag6V[9 aa]:UL40(15-23 H4C)[9 aa]:Gag6V(276-284 H4C)[9 aa]:Phenolphthiocerol/phthiocerol polyketide synthase ..:ESAT-6-like protein EsxH[9 aa]:Peptide from inhA[9 aa] 10 0 18 15 0 8 0 1 1 1 3 13 1 5 1 10 7 1 0 6 BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" ECO:0007744|PDB:7P49, ECO:0007744|PDB:7P4B":BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="2" /ligand_note="self-peptide antigen":TOPO_DOM:/note="Extracellular":BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" ECO:0007744|PDB:7P49, ECO:0007744|PDB:7P4B":BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="2" /ligand_note="self-peptide antigen":TOPO_DOM:/note="Extracellular" N->K:LB/B:rs1059510: -; 99 L H b 5.1 7p4b_C 1 0 1 2 12 1 0 19 1 59 0 0 1 0 1 1 1 1 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 100 R H e 53.4 7p4b_C TCB_HUMAN:KLRD1_HUMAN:TVB79_HUMAN:TJB12_HUMAN:K7N5M4_HUMAN:TVB14_HUMAN:TJB23_HUMAN:TRBC2_HUMAN:KK50.4 T cell receptor beta chain[240 aa]:Natural killer cells antigen CD94[123 aa]:Natural killer cells antigen CD94[121 aa]:GF4 T cell receptor beta chain[243 aa]:T-cell receptor beta chain[243 aa]:T-cell receptor beta chain[245 aa]:T-cell receptor beta chain[244 aa]:T cell receptor beta variable 7-9,M1-specific T ce..:T cell receptor beta variable 14,T cell receptor b..:T-cell receptor beta chain[241 aa] HLAE_HUMAN:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, ALPHA CHAI..:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN HLA-E[273 a.. SO4:GOL 8 0 1 9 0 4 0 0 15 3 0 2 0 8 43 1 0 0 5 0 MUTAGEN:/note="R->A: Reduces the affinity for KLRD1-KLRC1.":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="R->A: Reduces the affinity for KLRD1-KLRC1.":TOPO_DOM:/note="Extracellular" 101 T H e 28.6 7p4b_C TCB_HUMAN:Q0QI92_HCMV:HLAG_HUMAN:1C07_HUMAN:INHA_MYCTU:B6S6I4_9HIV1:TVB14_HUMAN:TJB23_HUMAN:TRBC2_HUMAN:PPSB_MYCTU:ESXH_MYCTU:Peptide VMAPRTVLL[9 aa]:Peptide VTAPRTLLL[9 aa]:PEPTIDE (VMAPRTVLL)[9 aa]:VMAPRTLIL peptide from CMV gpUL40[9 aa]:KK50.4 T cell receptor beta chain[240 aa]:Peptide from Glycoprotein[9 aa]:leader peptide of HLA class I histocompatibility a..:HLA class I histocompatibility antigen peptide[9 a..:GF4 T cell receptor beta chain[243 aa]:Mtb44*P2-Phe peptide variant (ARG-PHE-PRO-ALA-LYS-..:Enoyl-[acyl-carrier-protein] reductase [NADH][9 aa..:ARG-GLN-PRO-ALA-LYS-ALA-PRO-LEU-LEU[9 aa]:ARG-LEU-PRO-ALA-LYS-ALA-PRO-LEU-PHE[9 aa]:ARG-MET-TYR-SER-PRO-THR-SER-ILE-LEU[9 aa]:Enoyl-[acyl-carrier-protein] reductase [NADH][12 a..:VL9 leader peptide[9 aa]:Gag6V[9 aa]:UL40(15-23 H4C)[9 aa]:T cell receptor beta variable 14,T cell receptor b..:Gag6V(276-284 H4C)[9 aa]:Phenolphthiocerol/phthiocerol polyketide synthase ..:ESAT-6-like protein EsxH[9 aa]:Peptide from inhA[9 aa] 2 0 15 20 3 0 4 11 1 0 2 5 0 1 1 0 33 2 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 102 L H b 4.5 7p4b_C HLAG_HUMAN:1C07_HUMAN:PPSB_MYCTU:ESXH_MYCTU:Peptide VTAPRTLLL[9 aa]:PEPTIDE (VMAPRTVLL)[9 aa]:VMAPRTLIL peptide from CMV gpUL40[9 aa]:leader peptide of HLA class I histocompatibility a..:HLA class I histocompatibility antigen peptide[9 a..:Mtb44*P2-Phe peptide variant (ARG-PHE-PRO-ALA-LYS-..:ARG-GLN-PRO-ALA-LYS-ALA-PRO-LEU-LEU[9 aa]:ARG-LEU-PRO-ALA-LYS-ALA-PRO-LEU-PHE[9 aa]:ARG-MET-TYR-SER-PRO-THR-SER-ILE-LEU[9 aa]:VL9 leader peptide[9 aa]:UL40(15-23 H4C)[9 aa]:Gag6V(276-284 H4C)[9 aa]:Phenolphthiocerol/phthiocerol polyketide synthase ..:ESAT-6-like protein EsxH[9 aa]:Peptide from inhA[9 aa] 13 0 0 0 2 0 0 25 0 39 3 0 0 0 0 0 5 13 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 103 R H e 31.6 7p4b_C SO4 2 0 0 9 0 2 0 0 4 20 8 0 0 24 16 0 6 7 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 104 G H e 64.3 7p4b_C 8 0 15 8 0 29 4 1 8 1 0 2 1 0 13 5 1 3 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 105 Y H e 28.3 7p4b_C Q0QI92_HCMV:HLAG_HUMAN:1C07_HUMAN:INHA_MYCTU:B6S6I4_9HIV1:PPSB_MYCTU:ESXH_MYCTU:Peptide VMAPRTVLL[9 aa]:Peptide VTAPRTLLL[9 aa]:PEPTIDE (VMAPRTVLL)[9 aa]:VMAPRTLIL peptide from CMV gpUL40[9 aa]:Peptide from Glycoprotein[9 aa]:leader peptide of HLA class I histocompatibility a..:HLA class I histocompatibility antigen peptide[9 a..:Mtb44*P2-Phe peptide variant (ARG-PHE-PRO-ALA-LYS-..:Enoyl-[acyl-carrier-protein] reductase [NADH][9 aa..:ARG-GLN-PRO-ALA-LYS-ALA-PRO-LEU-LEU[9 aa]:ARG-LEU-PRO-ALA-LYS-ALA-PRO-LEU-PHE[9 aa]:ARG-MET-TYR-SER-PRO-THR-SER-ILE-LEU[9 aa]:Enoyl-[acyl-carrier-protein] reductase [NADH][12 a..:VL9 leader peptide[9 aa]:Gag6V[9 aa]:UL40(15-23 H4C)[9 aa]:Gag6V(276-284 H4C)[9 aa]:Phenolphthiocerol/phthiocerol polyketide synthase ..:ESAT-6-like protein EsxH[9 aa]:Peptide from inhA[9 aa] 0 0 0 0 12 0 6 5 0 8 10 5 0 7 8 0 0 0 0 35 BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" ECO:0007744|PDB:7P49, ECO:0007744|PDB:7P4B":BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="2" /ligand_note="self-peptide antigen":TOPO_DOM:/note="Extracellular":BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" ECO:0007744|PDB:7P49, ECO:0007744|PDB:7P4B":BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="2" /ligand_note="self-peptide antigen":TOPO_DOM:/note="Extracellular" 106 Y T e 31.7 7p4b_C HLAE_HUMAN:HLA class I histocompatibility antigen, alpha chai.. 5 0 3 10 3 1 3 4 5 2 10 0 0 0 7 1 0 7 0 38 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 107 N T e 93.3 7p4b_C HLAE_HUMAN:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, ALPHA CHAI..:HLA class I histocompatibility antigen, alpha chai.. 0 0 8 1 0 8 2 0 5 0 0 58 0 0 0 15 0 0 0 0 CARBOHYD:/note="N-linked (GlcNAc...) asparagine":TOPO_DOM:/note="Extracellular":CARBOHYD:/note="N-linked (GlcNAc...) asparagine":TOPO_DOM:/note="Extracellular" 108 Q e 27.6 7p4b_C B2MG_HUMAN:Beta-2-microglobulin[100 aa] HLAE_HUMAN:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, ALPHA CHAI..:HLA class I histocompatibility antigen, alpha chai.. SO4 3 0 11 3 3 2 12 3 0 2 3 0 6 42 0 1 0 3 0 5 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 109 S e 58.6 7p4b_C B2MG_HUMAN:BETA-2-MICROGLOBULIN[100 aa] HLAE_HUMAN:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, ALPHA CHAI..:HLA class I histocompatibility antigen, alpha chai.. SO4 4 0 1 1 9 3 0 3 12 6 0 0 1 2 4 45 9 1 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 110 E T e 73.4 7p4b_C B2MG_HUMAN:KLRD1_HUMAN:BETA-2-MICROGLOBULIN[100 aa]:Natural killer cells antigen CD94[123 aa] HLAE_HUMAN:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, ALPHA CHAI.. 5 0 7 31 1 1 0 1 12 2 0 5 11 13 3 4 1 1 0 1 MUTAGEN:/note="E->A: Has no impact on the affinity for KLRD1- KLRC1.":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="E->A: Has no impact on the affinity for KLRD1- KLRC1.":TOPO_DOM:/note="Extracellular" 111 A T e 67.0 7p4b_C B2MG_HUMAN:BETA-2-MICROGLOBULIN[100 aa] HLAE_HUMAN:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, ALPHA CHAI..:HLA class I histocompatibility antigen, alpha chai.. 10 0 12 5 3 17 0 1 12 4 9 2 1 4 3 5 5 4 0 3 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 112 G S e 31.0 7p4b_C 1 0 7 13 0 53 0 1 5 1 0 1 1 3 1 1 3 1 3 6 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 113 S e 50.0 7p4b_C B2MG_HUMAN:BETA-2-MICROGLOBULIN[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[98 aa] EDO 3 0 0 0 2 0 0 0 3 12 0 0 33 0 0 39 4 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 114 H b 12.0 7p4b_C B2MG_HUMAN:BETA-2-MICROGLOBULIN[100 aa]:Beta-2-microglobulin[100 aa] HLAE_HUMAN:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, ALPHA CHAI.. 0 0 0 0 20 0 53 6 0 8 0 0 0 0 0 0 0 0 0 8 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 115 T E e 22.7 7p4b_C B2MG_HUMAN:BETA-2-MICROGLOBULIN[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[99 aa] 0 0 2 17 0 0 0 5 0 0 0 0 0 0 0 5 49 22 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 116 L E b 2.2 7p4b_C HLAG_HUMAN:1C07_HUMAN:INHA_MYCTU:PEPTIDE (VMAPRTVLL)[9 aa]:leader peptide of HLA class I histocompatibility a..:HLA class I histocompatibility antigen peptide[9 a..:VMAPRTLIL peptide from CMV gpUL40[9 aa]:Enoyl-[acyl-carrier-protein] reductase [NADH][9 aa..:ARG-GLN-PRO-ALA-LYS-ALA-PRO-LEU-LEU[9 aa]:ARG-MET-TYR-SER-PRO-THR-SER-ILE-LEU[9 aa]:Enoyl-[acyl-carrier-protein] reductase [NADH][12 a..:VL9 leader peptide[9 aa]:UL40(15-23 H4C)[9 aa] 0 0 0 0 9 0 0 29 0 46 1 0 0 0 1 0 0 11 0 3 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 117 Q E e 40.3 7p4b_C B2MG_HUMAN:BETA-2-MICROGLOBULIN[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[97 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[99 aa] 0 0 0 0 0 0 0 0 0 0 0 0 0 95 0 0 5 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 118 W E b 15.5 7p4b_C B2MG_HUMAN:Q0QI92_HCMV:HLAG_HUMAN:1C07_HUMAN:INHA_MYCTU:B6S6I4_9HIV1:ESXH_MYCTU:BETA-2-MICROGLOBULIN[100 aa]:Peptide VMAPRTVLL[9 aa]:Peptide VTAPRTLLL[9 aa]:PEPTIDE (VMAPRTVLL)[9 aa]:Beta-2-microglobulin[100 aa]:VMAPRTLIL peptide from CMV gpUL40[9 aa]:Peptide from Glycoprotein[9 aa]:leader peptide of HLA class I histocompatibility a..:Beta-2-microglobulin[97 aa]:HLA class I histocompatibility antigen peptide[9 a..:Mtb44*P2-Phe peptide variant (ARG-PHE-PRO-ALA-LYS-..:Enoyl-[acyl-carrier-protein] reductase [NADH][9 aa..:ARG-GLN-PRO-ALA-LYS-ALA-PRO-LEU-LEU[9 aa]:ARG-LEU-PRO-ALA-LYS-ALA-PRO-LEU-PHE[9 aa]:ARG-MET-TYR-SER-PRO-THR-SER-ILE-LEU[9 aa]:Enoyl-[acyl-carrier-protein] reductase [NADH][12 a..:VL9 leader peptide[9 aa]:Beta-2-microglobulin[98 aa]:Gag6V[9 aa]:Beta-2-microglobulin[99 aa]:UL40(15-23 H4C)[9 aa]:Gag6V(276-284 H4C)[9 aa]:ESAT-6-like protein EsxH[9 aa]:Peptide from inhA[9 aa] 10 0 2 4 13 21 0 6 0 5 0 0 0 0 8 1 1 14 15 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 119 M E e 28.5 7p4b_C B2MG_HUMAN:BETA-2-MICROGLOBULIN[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[97 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[99 aa] 3 0 0 2 1 0 0 20 9 9 28 0 0 2 8 8 10 1 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 120 H E b 5.8 7p4b_C HLAG_HUMAN:1C07_HUMAN:INHA_MYCTU:Peptide VMAPRTVLL[9 aa]:Peptide VTAPRTLLL[9 aa]:VMAPRTLIL peptide from CMV gpUL40[9 aa]:leader peptide of HLA class I histocompatibility a..:HLA class I histocompatibility antigen peptide[9 a..:Mtb44*P2-Phe peptide variant (ARG-PHE-PRO-ALA-LYS-..:Enoyl-[acyl-carrier-protein] reductase [NADH][9 aa..:ARG-GLN-PRO-ALA-LYS-ALA-PRO-LEU-LEU[9 aa]:ARG-LEU-PRO-ALA-LYS-ALA-PRO-LEU-PHE[9 aa]:ARG-MET-TYR-SER-PRO-THR-SER-ILE-LEU[9 aa]:Enoyl-[acyl-carrier-protein] reductase [NADH][12 a..:VL9 leader peptide[9 aa]:UL40(15-23 H4C)[9 aa]:Gag6V(276-284 H4C)[9 aa]:Peptide from inhA[9 aa] 21 0 0 2 7 12 7 4 0 14 7 1 2 0 4 2 2 0 0 17 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 121 G E b 1.2 7p4b_C 0 0 1 11 2 72 0 0 0 0 3 0 0 0 0 7 0 4 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 122 C E b 0.0 7p4b_C 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DISULFID:ECO:0000269|PubMed:30087334, ECO:0000269|PubMed:35705051, ECO:0007744|PDB:7P49":TOPO_DOM:/note="Extracellular":DISULFID:ECO:0000269|PubMed:30087334, ECO:0000269|PubMed:35705051, ECO:0007744|PDB:7P49":TOPO_DOM:/note="Extracellular" 123 E E e 23.1 7p4b_C GOL 0 0 18 60 0 1 3 0 1 0 0 5 0 0 2 0 0 0 0 10 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 124 L E b 1.1 7p4b_C 0 2 0 0 12 0 0 8 0 40 11 0 0 4 0 0 5 16 0 1 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 125 G b 3.6 7p4b_C 3 0 0 5 0 23 21 2 4 6 0 2 0 5 1 0 14 0 1 10 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 126 P T e 74.4 7p4b_C 9 0 0 15 1 1 5 0 1 2 0 13 28 0 4 18 1 1 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 127 D T e 75.9 7p4b_C 1 0 35 6 1 20 2 0 1 1 0 12 2 0 3 13 1 1 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 128 G S e 21.4 7p4b_C 0 0 0 1 0 65 0 0 0 0 0 15 0 2 0 2 12 0 1 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" G->R:LB/B:rs1264457: -; 129 R e 74.3 7p4b_C SO4 2 0 0 10 0 2 4 2 6 0 0 7 1 12 22 28 3 2 0 0 MUTAGEN:/note="R->A: Has no impact on the affinity for KLRD1- KLRC1.":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="R->A: Has no impact on the affinity for KLRD1- KLRC1.":TOPO_DOM:/note="Extracellular" 130 F E e 31.6 7p4b_C 10 0 1 1 29 3 3 2 1 13 0 1 3 1 8 12 4 2 0 7 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 131 L E e 65.2 7p4b_C 0 0 0 0 3 0 0 11 0 30 0 0 3 1 1 12 20 18 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 132 R E e 31.2 7p4b_C B2MG_HUMAN:Beta-2-microglobulin[100 aa] GOL 4 0 0 9 0 4 3 0 5 0 1 10 5 1 45 6 6 1 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 133 G E b 6.0 7p4b_C 5 0 1 1 4 55 0 1 4 4 0 2 1 0 2 15 1 1 0 4 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 134 Y E b 2.6 7p4b_C B2MG_HUMAN:Beta-2-microglobulin[100 aa] GOL 1 0 1 1 28 1 1 1 1 7 1 0 1 0 1 12 11 11 0 22 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 135 E E b 1.5 7p4b_C INHA_MYCTU:B6S6I4_9HIV1:PPSB_MYCTU:Mtb44*P2-Phe peptide variant (ARG-PHE-PRO-ALA-LYS-..:Enoyl-[acyl-carrier-protein] reductase [NADH][9 aa..:ARG-GLN-PRO-ALA-LYS-ALA-PRO-LEU-LEU[9 aa]:Gag6V[9 aa]:UL40(15-23 H4C)[9 aa]:Gag6V(276-284 H4C)[9 aa]:Phenolphthiocerol/phthiocerol polyketide synthase .. 8 1 7 21 8 2 1 3 1 15 1 1 1 3 3 2 6 2 15 1 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 136 Q E e 25.5 7p4b_C B2MG_HUMAN:BETA-2-MICROGLOBULIN[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[97 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[99 aa] GOL 1 0 0 3 0 5 15 0 11 1 0 0 0 26 29 1 3 3 0 1 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 137 F E b 17.2 7p4b_C B2MG_HUMAN:Q0QI92_HCMV:HLAG_HUMAN:INHA_MYCTU:PPSB_MYCTU:ESXH_MYCTU:BETA-2-MICROGLOBULIN[100 aa]:Peptide VMAPRTVLL[9 aa]:Peptide VTAPRTLLL[9 aa]:PEPTIDE (VMAPRTVLL)[9 aa]:Beta-2-microglobulin[100 aa]:VMAPRTLIL peptide from CMV gpUL40[9 aa]:Peptide from Glycoprotein[9 aa]:leader peptide of HLA class I histocompatibility a..:Beta-2-microglobulin[97 aa]:HLA class I histocompatibility antigen peptide[9 a..:Mtb44*P2-Phe peptide variant (ARG-PHE-PRO-ALA-LYS-..:Enoyl-[acyl-carrier-protein] reductase [NADH][9 aa..:ARG-GLN-PRO-ALA-LYS-ALA-PRO-LEU-LEU[9 aa]:ARG-LEU-PRO-ALA-LYS-ALA-PRO-LEU-PHE[9 aa]:ARG-MET-TYR-SER-PRO-THR-SER-ILE-LEU[9 aa]:Enoyl-[acyl-carrier-protein] reductase [NADH][12 a..:VL9 leader peptide[9 aa]:Beta-2-microglobulin[99 aa]:UL40(15-23 H4C)[9 aa]:Gag6V(276-284 H4C)[9 aa]:Phenolphthiocerol/phthiocerol polyketide synthase ..:ESAT-6-like protein EsxH[9 aa]:Peptide from inhA[9 aa] 3 1 2 1 21 5 5 1 0 10 2 0 0 0 1 1 0 15 0 26 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 138 A E b 15.2 7p4b_C B2MG_HUMAN:BETA-2-MICROGLOBULIN[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[97 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[99 aa] 48 0 3 2 4 12 0 13 0 0 0 0 0 0 4 4 3 1 0 4 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 139 Y E b 6.5 7p4b_C 0 3 0 0 21 3 2 1 0 12 0 0 0 0 0 0 0 2 4 54 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 140 D T e 42.6 7p4b_C B2MG_HUMAN:BETA-2-MICROGLOBULIN[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[97 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[99 aa] HLAE_HUMAN:HLA class I histocompatibility antigen, alpha chai.. 0 0 41 6 0 6 0 0 0 5 0 30 0 11 0 0 0 2 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 141 G T e 73.8 7p4b_C B2MG_HUMAN:BETA-2-MICROGLOBULIN[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[97 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[99 aa] 0 0 0 4 0 69 2 0 0 3 0 0 0 7 10 0 2 3 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 142 K E e 64.6 7p4b_C B2MG_HUMAN:BETA-2-MICROGLOBULIN[100 aa]:Beta-2-microglobulin[100 aa] 1 2 2 32 0 0 0 0 13 14 1 0 1 16 12 3 3 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 143 D E e 59.3 7p4b_C B2MG_HUMAN:BETA-2-MICROGLOBULIN[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[97 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[99 aa] 0 0 43 26 3 0 2 3 2 3 0 8 0 1 0 0 4 0 0 6 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 144 Y E b 4.3 7p4b_C HLAG_HUMAN:1C07_HUMAN:INHA_MYCTU:Peptide VMAPRTVLL[9 aa]:Peptide VTAPRTLLL[9 aa]:VMAPRTLIL peptide from CMV gpUL40[9 aa]:leader peptide of HLA class I histocompatibility a..:HLA class I histocompatibility antigen peptide[9 a..:ARG-LEU-PRO-ALA-LYS-ALA-PRO-LEU-PHE[9 aa]:Enoyl-[acyl-carrier-protein] reductase [NADH][9 aa..:Enoyl-[acyl-carrier-protein] reductase [NADH][12 a.. 2 0 0 0 39 0 4 6 0 10 0 3 0 2 0 1 0 5 0 28 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 145 L E b 2.8 7p4b_C Q0QI92_HCMV:HLAG_HUMAN:1C07_HUMAN:INHA_MYCTU:B6S6I4_9HIV1:PPSB_MYCTU:Peptide VMAPRTVLL[9 aa]:Peptide VTAPRTLLL[9 aa]:VMAPRTLIL peptide from CMV gpUL40[9 aa]:Peptide from Glycoprotein[9 aa]:leader peptide of HLA class I histocompatibility a..:HLA class I histocompatibility antigen peptide[9 a..:Mtb44*P2-Phe peptide variant (ARG-PHE-PRO-ALA-LYS-..:Enoyl-[acyl-carrier-protein] reductase [NADH][9 aa..:ARG-GLN-PRO-ALA-LYS-ALA-PRO-LEU-LEU[9 aa]:ARG-LEU-PRO-ALA-LYS-ALA-PRO-LEU-PHE[9 aa]:ARG-MET-TYR-SER-PRO-THR-SER-ILE-LEU[9 aa]:Enoyl-[acyl-carrier-protein] reductase [NADH][12 a..:VL9 leader peptide[9 aa]:Gag6V[9 aa]:UL40(15-23 H4C)[9 aa]:Phenolphthiocerol/phthiocerol polyketide synthase ..:Peptide from inhA[9 aa] 3 0 0 0 2 1 0 16 0 40 9 0 0 0 0 0 5 19 0 4 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 146 T E b 13.0 7p4b_C 12 0 3 10 0 0 1 2 2 4 0 6 0 0 24 25 8 1 0 2 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 147 L E b 5.6 7p4b_C 0 0 0 0 53 0 0 6 0 20 0 0 0 7 0 0 0 5 0 9 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 148 N e 23.6 7p4b_C 0 3 35 6 0 3 1 0 9 0 0 27 0 11 3 0 0 0 1 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 149 E T e 68.3 7p4b_C 0 0 4 18 0 9 1 0 8 5 0 13 6 4 3 28 0 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 150 D T e 29.6 7p4b_C TVB14_HUMAN:TJB23_HUMAN:TRBC2_HUMAN:T cell receptor beta variable 14,T cell receptor b.. 1 1 43 10 0 1 2 1 11 0 0 10 0 0 2 4 8 3 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 151 L S b 2.2 7p4b_C TVB14_HUMAN:TJB23_HUMAN:TRBC2_HUMAN:T cell receptor beta variable 14,T cell receptor b.. 1 0 1 4 1 1 0 6 3 30 2 4 1 2 1 1 18 22 0 1 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 152 R S e 63.2 7p4b_C NKG2A_HUMAN:TVB14_HUMAN:TJB23_HUMAN:TRBC2_HUMAN:NKG2-A/NKG2-B type II integral membrane protein[11..:T cell receptor beta variable 14,T cell receptor b.. SO4 1 0 1 4 1 25 0 4 10 11 2 1 7 2 17 2 8 3 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 153 S e 30.5 7p4b_C 6 1 2 19 4 0 0 1 4 5 4 5 2 0 0 28 12 5 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 154 W E b 6.4 7p4b_C Q0QI92_HCMV:HLAG_HUMAN:1C07_HUMAN:INHA_MYCTU:PPSB_MYCTU:Peptide VMAPRTVLL[9 aa]:Peptide VTAPRTLLL[9 aa]:VMAPRTLIL peptide from CMV gpUL40[9 aa]:Peptide from Glycoprotein[9 aa]:leader peptide of HLA class I histocompatibility a..:HLA class I histocompatibility antigen peptide[9 a..:Enoyl-[acyl-carrier-protein] reductase [NADH][12 a..:VL9 leader peptide[9 aa]:UL40(15-23 H4C)[9 aa]:Phenolphthiocerol/phthiocerol polyketide synthase .. EDO 1 1 4 0 13 0 1 0 3 0 0 0 4 0 0 4 0 0 60 8 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 155 T E e 42.9 7p4b_C 2 0 2 8 0 1 1 1 0 4 1 0 3 6 17 11 34 7 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 156 A E e 20.5 7p4b_C 50 5 4 2 0 12 0 0 1 0 2 0 9 0 2 2 7 4 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 157 V e 42.7 7p4b_C 16 1 7 2 1 7 0 0 0 4 2 1 6 3 0 2 0 42 2 1 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 158 D S e 25.3 7p4b_C SO4 0 0 21 6 0 9 5 1 3 2 0 6 12 0 0 3 23 2 6 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 159 T H e 68.2 7p4b_C SO4 4 0 1 24 1 3 0 1 2 6 6 2 17 0 7 4 13 4 0 4 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 160 A H b 5.4 7p4b_C INHA_MYCTU:Enoyl-[acyl-carrier-protein] reductase [NADH][12 a.. 33 3 1 8 1 9 3 0 0 23 0 0 5 0 5 2 0 4 0 4 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 161 A H b 0.0 7p4b_C EDO 31 0 0 3 0 22 0 5 2 4 4 0 7 6 5 1 8 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 162 Q H e 52.6 7p4b_C INHA_MYCTU:Enoyl-[acyl-carrier-protein] reductase [NADH][12 a.. EDO 7 0 2 5 0 3 2 0 6 6 0 10 5 22 21 7 0 1 3 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 163 I H e 46.8 7p4b_C INHA_MYCTU:Enoyl-[acyl-carrier-protein] reductase [NADH][12 a.. HLAE_HUMAN:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, ALPHA CHAI..:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN HLA-E[273 a.. EDO 2 0 0 0 7 4 0 27 4 2 4 2 16 2 1 4 3 18 5 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 164 S H b 16.4 7p4b_C Q0QI92_HCMV:HLAG_HUMAN:1C07_HUMAN:INHA_MYCTU:B6S6I4_9HIV1:PPSB_MYCTU:ESXH_MYCTU:Peptide VMAPRTVLL[9 aa]:Peptide VTAPRTLLL[9 aa]:PEPTIDE (VMAPRTVLL)[9 aa]:VMAPRTLIL peptide from CMV gpUL40[9 aa]:Peptide from Glycoprotein[9 aa]:leader peptide of HLA class I histocompatibility a..:HLA class I histocompatibility antigen peptide[9 a..:Mtb44*P2-Phe peptide variant (ARG-PHE-PRO-ALA-LYS-..:Enoyl-[acyl-carrier-protein] reductase [NADH][9 aa..:ARG-GLN-PRO-ALA-LYS-ALA-PRO-LEU-LEU[9 aa]:ARG-LEU-PRO-ALA-LYS-ALA-PRO-LEU-PHE[9 aa]:ARG-MET-TYR-SER-PRO-THR-SER-ILE-LEU[9 aa]:Enoyl-[acyl-carrier-protein] reductase [NADH][12 a..:VL9 leader peptide[9 aa]:Gag6V[9 aa]:UL40(15-23 H4C)[9 aa]:Gag6V(276-284 H4C)[9 aa]:Phenolphthiocerol/phthiocerol polyketide synthase ..:ESAT-6-like protein EsxH[9 aa]:Peptide from inhA[9 aa] 7 7 9 1 2 0 0 3 7 9 1 2 0 0 2 16 27 5 2 1 BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" ECO:0000269|PubMed:35705051, ECO:0007744|PDB:7P49, ECO:0007744|PDB:7P4B":BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="2" /ligand_note="self-peptide antigen":TOPO_DOM:/note="Extracellular":BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" ECO:0000269|PubMed:35705051, ECO:0007744|PDB:7P49, ECO:0007744|PDB:7P4B":BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="2" /ligand_note="self-peptide antigen":TOPO_DOM:/note="Extracellular" 165 E H e 24.6 7p4b_C 21 4 2 18 0 2 0 0 24 0 0 4 2 8 10 0 1 3 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 166 Q H e 53.6 7p4b_C GF4 T cell receptor beta chain[243 aa]:T-cell receptor beta chain[245 aa] HLAE_HUMAN:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, ALPHA CHAI..:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN HLA-E[273 a.. 5 0 6 13 5 0 5 1 7 16 3 3 0 12 14 6 2 3 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 167 K H e 53.3 7p4b_C TCB_HUMAN:Q0QI92_HCMV:HLAG_HUMAN:1C07_HUMAN:INHA_MYCTU:B6S6I4_9HIV1:TVB14_HUMAN:TJB23_HUMAN:TRBC2_HUMAN:PPSB_MYCTU:ESXH_MYCTU:Peptide VMAPRTVLL[9 aa]:Peptide VTAPRTLLL[9 aa]:PEPTIDE (VMAPRTVLL)[9 aa]:VMAPRTLIL peptide from CMV gpUL40[9 aa]:KK50.4 T cell receptor beta chain[240 aa]:Peptide from Glycoprotein[9 aa]:leader peptide of HLA class I histocompatibility a..:HLA class I histocompatibility antigen peptide[9 a..:GF4 T cell receptor beta chain[243 aa]:Mtb44*P2-Phe peptide variant (ARG-PHE-PRO-ALA-LYS-..:Enoyl-[acyl-carrier-protein] reductase [NADH][9 aa..:ARG-GLN-PRO-ALA-LYS-ALA-PRO-LEU-LEU[9 aa]:ARG-LEU-PRO-ALA-LYS-ALA-PRO-LEU-PHE[9 aa]:ARG-MET-TYR-SER-PRO-THR-SER-ILE-LEU[9 aa]:Enoyl-[acyl-carrier-protein] reductase [NADH][12 a..:T-cell receptor beta chain[245 aa]:VL9 leader peptide[9 aa]:Gag6V[9 aa]:T cell receptor beta variable 14,T cell receptor b..:Gag6V(276-284 H4C)[9 aa]:Phenolphthiocerol/phthiocerol polyketide synthase ..:ESAT-6-like protein EsxH[9 aa]:Peptide from inhA[9 aa] HLAE_HUMAN:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, ALPHA CHAI..:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN HLA-E[273 a.. 1 0 2 4 7 4 3 5 26 13 0 6 0 4 0 1 3 2 10 8 BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" ECO:0000269|PubMed:35705051, ECO:0007744|PDB:7P49, ECO:0007744|PDB:7P4B":BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="2" /ligand_note="self-peptide antigen":MUTAGEN:/note="K->A: Impairs folding.":TOPO_DOM:/note="Extracellular":BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" ECO:0000269|PubMed:35705051, ECO:0007744|PDB:7P49, ECO:0007744|PDB:7P4B":BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="2" /ligand_note="self-peptide antigen":MUTAGEN:/note="K->A: Impairs folding.":TOPO_DOM:/note="Extracellular" 168 S H e 20.3 7p4b_C Q0QI92_HCMV:HLAG_HUMAN:1C07_HUMAN:INHA_MYCTU:B6S6I4_9HIV1:PPSB_MYCTU:ESXH_MYCTU:Peptide VMAPRTVLL[9 aa]:Peptide VTAPRTLLL[9 aa]:PEPTIDE (VMAPRTVLL)[9 aa]:VMAPRTLIL peptide from CMV gpUL40[9 aa]:Peptide from Glycoprotein[9 aa]:leader peptide of HLA class I histocompatibility a..:HLA class I histocompatibility antigen peptide[9 a..:T-cell receptor beta chain[245 aa]:Enoyl-[acyl-carrier-protein] reductase [NADH][9 aa..:VL9 leader peptide[9 aa]:Gag6V[9 aa]:UL40(15-23 H4C)[9 aa]:Gag6V(276-284 H4C)[9 aa]:Phenolphthiocerol/phthiocerol polyketide synthase ..:ESAT-6-like protein EsxH[9 aa]:Peptide from inhA[9 aa] 4 3 0 11 6 0 0 5 7 5 1 8 3 3 7 7 1 0 27 3 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 169 N H e 41.8 7p4b_C NKG2A_HUMAN:NKG2-A/NKG2-B type II integral membrane protein[11..:GF4 T cell receptor alpha chain[201 aa]:GF4 T cell receptor alpha chain[202 aa] 7 1 5 19 7 1 0 0 7 1 2 25 6 8 2 2 3 2 1 1 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 170 D H e 72.2 7p4b_C NKG2A_HUMAN:TVB14_HUMAN:TJB23_HUMAN:TRBC2_HUMAN:Peptide VMAPRTVLL[9 aa]:Peptide VTAPRTLLL[9 aa]:NKG2-A/NKG2-B type II integral membrane protein[11..:GF4 T cell receptor alpha chain[201 aa]:GF4 T cell receptor alpha chain[202 aa]:T-cell receptor alpha chain[188 aa]:T-cell receptor beta chain[243 aa]:T-cell receptor alpha chain[189 aa]:T-cell receptor beta chain[244 aa]:T cell receptor beta variable 14,T cell receptor b..:T-cell receptor alpha chain[187 aa] HLAE_HUMAN:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, ALPHA CHAI..:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN HLA-E[273 a.. EDO 11 3 23 5 0 1 3 0 4 0 0 11 0 10 4 12 2 1 0 9 MUTAGEN:/note="D->A: Has no impact on the affinity for KLRD1- KLRC1.":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="D->A: Has no impact on the affinity for KLRD1- KLRC1.":TOPO_DOM:/note="Extracellular" 171 A T e 54.5 7p4b_C TCB_HUMAN:B6S6I4_9HIV1:TVA4_HUMAN:A0A075B6U7_HUMAN:TRAR1_HUMAN:TVB14_HUMAN:TJB23_HUMAN:TRBC2_HUMAN:PEPTIDE (VMAPRTVLL)[9 aa]:KK50.4 T cell receptor beta chain[240 aa]:GF4 T cell receptor alpha chain[202 aa]:GF4 T cell receptor beta chain[243 aa]:ARG-MET-TYR-SER-PRO-THR-SER-ILE-LEU[9 aa]:T-cell receptor alpha chain[188 aa]:T-cell receptor beta chain[243 aa]:T-cell receptor alpha chain[189 aa]:T-cell receptor beta chain[244 aa]:Gag6V[9 aa]:TCR Gag:02-alpha,TCR Gag:02-alpha,TCR Gag:02-alpha..:T cell receptor beta variable 14,T cell receptor b..:Gag6V(276-284 H4C)[9 aa]:T-cell receptor alpha chain[187 aa] HLAE_HUMAN:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, ALPHA CHAI..:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN HLA-E[273 a.. 26 0 3 3 0 3 5 4 12 6 0 1 6 20 2 2 5 2 0 2 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 172 S T e 41.4 7p4b_C NKG2A_HUMAN:NKG2-A/NKG2-B type II integral membrane protein[11..:NKG2-A/NKG2-B type II integral membrane protein[12..:GF4 T cell receptor alpha chain[201 aa]:GF4 T cell receptor alpha chain[202 aa]:GF4 T cell receptor alpha chain[199 aa]:T-cell receptor alpha chain[190 aa]:T-cell receptor alpha chain[189 aa]:T-cell receptor alpha chain[187 aa] HLAE_HUMAN:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, ALPHA CHAI.. 2 1 5 8 4 17 3 2 11 2 3 2 12 7 4 5 3 4 2 4 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 173 E H e 27.1 7p4b_C TCB_HUMAN:Q0QI92_HCMV:HLAG_HUMAN:1C07_HUMAN:KLRD1_HUMAN:INHA_MYCTU:TVA4_HUMAN:A0A075B6U7_HUMAN:TRAR1_HUMAN:TVB14_HUMAN:TJB23_HUMAN:TRBC2_HUMAN:PPSB_MYCTU:ESXH_MYCTU:Peptide VMAPRTVLL[9 aa]:Peptide VTAPRTLLL[9 aa]:PEPTIDE (VMAPRTVLL)[9 aa]:VMAPRTLIL peptide from CMV gpUL40[9 aa]:KK50.4 T cell receptor beta chain[240 aa]:Peptide from Glycoprotein[9 aa]:leader peptide of HLA class I histocompatibility a..:Natural killer cells antigen CD94[123 aa]:HLA class I histocompatibility antigen peptide[9 a..:Natural killer cells antigen CD94[121 aa]:GF4 T cell receptor alpha chain[201 aa]:Mtb44*P2-Phe peptide variant (ARG-PHE-PRO-ALA-LYS-..:Enoyl-[acyl-carrier-protein] reductase [NADH][9 aa..:ARG-GLN-PRO-ALA-LYS-ALA-PRO-LEU-LEU[9 aa]:ARG-LEU-PRO-ALA-LYS-ALA-PRO-LEU-PHE[9 aa]:ARG-MET-TYR-SER-PRO-THR-SER-ILE-LEU[9 aa]:T-cell receptor alpha chain[188 aa]:T-cell receptor beta chain[243 aa]:Enoyl-[acyl-carrier-protein] reductase [NADH][12 a..:T-cell receptor alpha chain[190 aa]:T-cell receptor beta chain[245 aa]:T-cell receptor alpha chain[189 aa]:T-cell receptor beta chain[244 aa]:VL9 leader peptide[9 aa]:TCR Gag:02-alpha,TCR Gag:02-alpha,TCR Gag:02-alpha..:UL40(15-23 H4C)[9 aa]:T cell receptor beta variable 14,T cell receptor b..:Phenolphthiocerol/phthiocerol polyketide synthase ..:ESAT-6-like protein EsxH[9 aa]:Peptide from inhA[9 aa] ZN 5 0 7 26 4 4 0 10 4 5 0 0 0 1 7 6 7 2 0 11 MUTAGEN:/note="E->A: Impairs the recognition by KLRD1-KLRC1.":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="E->A: Impairs the recognition by KLRD1-KLRC1.":TOPO_DOM:/note="Extracellular" 174 A H b 1.8 7p4b_C TVA4_HUMAN:A0A075B6U7_HUMAN:TRAR1_HUMAN:TVB14_HUMAN:TJB23_HUMAN:TRBC2_HUMAN:TCR Gag:02-alpha,TCR Gag:02-alpha,TCR Gag:02-alpha..:T cell receptor beta variable 14,T cell receptor b..:T cell receptor alpha variable 4,T cell receptor a.. 40 2 0 0 2 6 0 9 4 12 3 1 1 0 4 1 6 5 3 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 175 E H e 57.3 7p4b_C TCA_HUMAN:NKG2A_HUMAN:TVA4_HUMAN:A0A075B6U7_HUMAN:TRAR1_HUMAN:TVAZ1_HUMAN:A0A087X096_HUMAN:TRAC_HUMAN:TVB14_HUMAN:TJB23_HUMAN:TRBC2_HUMAN:KK50.4 T cell receptor alpha chain[199 aa]:NKG2-A/NKG2-B type II integral membrane protein[11..:NKG2-A/NKG2-B type II integral membrane protein[12..:GF4 T cell receptor alpha chain[201 aa]:GF4 T cell receptor alpha chain[202 aa]:T-cell receptor alpha chain[188 aa]:T-cell receptor alpha chain[190 aa]:T-cell receptor alpha chain[189 aa]:TCR Gag:02-alpha,TCR Gag:02-alpha,TCR Gag:02-alpha..:T cell receptor alpha variable 26-1,T cell recepto..:T cell receptor beta variable 14,T cell receptor b..:T cell receptor alpha variable 4,T cell receptor a..:T-cell receptor alpha chain[187 aa] 1 0 13 39 0 0 1 1 4 8 1 7 1 10 3 0 7 4 0 0 MUTAGEN:/note="E->A: Has no impact on the affinity for KLRD1- KLRC1.":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="E->A: Has no impact on the affinity for KLRD1- KLRC1.":TOPO_DOM:/note="Extracellular" 176 H H e 62.3 7p4b_C TCA_HUMAN:TCB_HUMAN:Q0QI92_HCMV:HLAG_HUMAN:1C07_HUMAN:NKG2A_HUMAN:INHA_MYCTU:B6S6I4_9HIV1:TVA4_HUMAN:A0A075B6U7_HUMAN:TRAR1_HUMAN:TVB79_HUMAN:TJB12_HUMAN:K7N5M4_HUMAN:TVAZ1_HUMAN:A0A087X096_HUMAN:TRAC_HUMAN:TVB14_HUMAN:TJB23_HUMAN:TRBC2_HUMAN:PPSB_MYCTU:ESXH_MYCTU:Peptide VMAPRTVLL[9 aa]:Peptide VTAPRTLLL[9 aa]:PEPTIDE (VMAPRTVLL)[9 aa]:VMAPRTLIL peptide from CMV gpUL40[9 aa]:KK50.4 T cell receptor alpha chain[199 aa]:KK50.4 T cell receptor beta chain[240 aa]:Peptide from Glycoprotein[9 aa]:leader peptide of HLA class I histocompatibility a..:NKG2-A/NKG2-B type II integral membrane protein[11..:NKG2-A/NKG2-B type II integral membrane protein[12..:HLA class I histocompatibility antigen peptide[9 a..:GF4 T cell receptor alpha chain[201 aa]:GF4 T cell receptor alpha chain[202 aa]:GF4 T cell receptor alpha chain[199 aa]:Mtb44*P2-Phe peptide variant (ARG-PHE-PRO-ALA-LYS-..:ARG-MET-TYR-SER-PRO-THR-SER-ILE-LEU[9 aa]:Enoyl-[acyl-carrier-protein] reductase [NADH][9 aa..:T-cell receptor alpha chain[188 aa]:Enoyl-[acyl-carrier-protein] reductase [NADH][12 a..:T-cell receptor alpha chain[190 aa]:T-cell receptor alpha chain[189 aa]:3H4 Fab heavy chain[225 aa]:VL9 leader peptide[9 aa]:3H4 Fab heavy chain[218 aa]:Gag6V[9 aa]:TCR Gag:02-alpha,TCR Gag:02-alpha,TCR Gag:02-alpha..:T cell receptor beta variable 7-9,M1-specific T ce..:UL40(15-23 H4C)[9 aa]:T cell receptor alpha variable 26-1,T cell recepto..:T cell receptor beta variable 14,T cell receptor b..:Gag6V(276-284 H4C)[9 aa]:T cell receptor alpha variable 4,T cell receptor a..:T cell receptor beta variable 7-9,T cell receptor ..:Phenolphthiocerol/phthiocerol polyketide synthase ..:ESAT-6-like protein EsxH[9 aa]:Peptide from inhA[9 aa]:T-cell receptor alpha chain[187 aa] ZN HLAE_HUMAN:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, ALPHA CHAI..:HLA CLASS I HISTOCOMPATIBILITY ANTIGEN HLA-E[273 a.. SO4 0 0 1 6 2 3 4 7 7 5 3 0 0 17 15 7 14 3 0 7 MUTAGEN:/note="H->A: Has no impact on the affinity for KLRD1- KLRC1.":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="H->A: Has no impact on the affinity for KLRD1- KLRC1.":TOPO_DOM:/note="Extracellular" 177 Q H b 6.1 7p4b_C Q0QI92_HCMV:HLAG_HUMAN:1C07_HUMAN:INHA_MYCTU:B6S6I4_9HIV1:PPSB_MYCTU:ESXH_MYCTU:Peptide VMAPRTVLL[9 aa]:Peptide VTAPRTLLL[9 aa]:PEPTIDE (VMAPRTVLL)[9 aa]:VMAPRTLIL peptide from CMV gpUL40[9 aa]:Peptide from Glycoprotein[9 aa]:leader peptide of HLA class I histocompatibility a..:HLA class I histocompatibility antigen peptide[9 a..:Mtb44*P2-Phe peptide variant (ARG-PHE-PRO-ALA-LYS-..:Enoyl-[acyl-carrier-protein] reductase [NADH][9 aa..:ARG-GLN-PRO-ALA-LYS-ALA-PRO-LEU-LEU[9 aa]:ARG-MET-TYR-SER-PRO-THR-SER-ILE-LEU[9 aa]:Enoyl-[acyl-carrier-protein] reductase [NADH][12 a..:VL9 leader peptide[9 aa]:Gag6V[9 aa]:UL40(15-23 H4C)[9 aa]:Gag6V(276-284 H4C)[9 aa]:Phenolphthiocerol/phthiocerol polyketide synthase ..:ESAT-6-like protein EsxH[9 aa]:Peptide from inhA[9 aa] 6 0 2 13 4 0 3 4 6 5 2 9 0 19 4 4 6 10 1 2 BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="2" /ligand_note="self-peptide antigen":TOPO_DOM:/note="Extracellular":BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="2" /ligand_note="self-peptide antigen":TOPO_DOM:/note="Extracellular" 178 R H e 39.1 7p4b_C TCA_HUMAN:NKG2A_HUMAN:TVA4_HUMAN:A0A075B6U7_HUMAN:TRAR1_HUMAN:TVB14_HUMAN:TJB23_HUMAN:TRBC2_HUMAN:KK50.4 T cell receptor alpha chain[199 aa]:NKG2-A/NKG2-B type II integral membrane protein[11..:TCR Gag:02-alpha,TCR Gag:02-alpha,TCR Gag:02-alpha..:T cell receptor beta variable 14,T cell receptor b..:T cell receptor alpha variable 4,T cell receptor a.. SO4 5 0 1 5 2 1 3 6 19 2 0 1 0 6 43 0 2 2 0 1 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" R->G:LB/B:rs4156231: -; 179 A H e 38.4 7p4b_C TCA_HUMAN:NKG2A_HUMAN:TVA4_HUMAN:A0A075B6U7_HUMAN:TRAR1_HUMAN:TVAZ1_HUMAN:A0A087X096_HUMAN:TRAC_HUMAN:KK50.4 T cell receptor alpha chain[199 aa]:NKG2-A/NKG2-B type II integral membrane protein[11..:NKG2-A/NKG2-B type II integral membrane protein[12..:GF4 T cell receptor alpha chain[201 aa]:GF4 T cell receptor alpha chain[202 aa]:GF4 T cell receptor alpha chain[199 aa]:3H4 Fab heavy chain[225 aa]:3H4 Fab heavy chain[218 aa]:TCR Gag:02-alpha,TCR Gag:02-alpha,TCR Gag:02-alpha..:T cell receptor alpha variable 26-1,T cell recepto..:T cell receptor alpha variable 4,T cell receptor a..:T-cell receptor alpha chain[187 aa] 40 0 6 1 0 1 3 5 2 1 3 12 0 1 4 5 9 2 3 3 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 180 Y H e 29.6 7p4b_C Q0QI92_HCMV:HLAG_HUMAN:1C07_HUMAN:INHA_MYCTU:B6S6I4_9HIV1:PPSB_MYCTU:ESXH_MYCTU:Peptide VMAPRTVLL[9 aa]:Peptide VTAPRTLLL[9 aa]:PEPTIDE (VMAPRTVLL)[9 aa]:VMAPRTLIL peptide from CMV gpUL40[9 aa]:Peptide from Glycoprotein[9 aa]:leader peptide of HLA class I histocompatibility a..:HLA class I histocompatibility antigen peptide[9 a..:Mtb44*P2-Phe peptide variant (ARG-PHE-PRO-ALA-LYS-..:Enoyl-[acyl-carrier-protein] reductase [NADH][9 aa..:ARG-GLN-PRO-ALA-LYS-ALA-PRO-LEU-LEU[9 aa]:ARG-LEU-PRO-ALA-LYS-ALA-PRO-LEU-PHE[9 aa]:ARG-MET-TYR-SER-PRO-THR-SER-ILE-LEU[9 aa]:Enoyl-[acyl-carrier-protein] reductase [NADH][12 a..:VL9 leader peptide[9 aa]:Gag6V[9 aa]:UL40(15-23 H4C)[9 aa]:Gag6V(276-284 H4C)[9 aa]:Phenolphthiocerol/phthiocerol polyketide synthase ..:ESAT-6-like protein EsxH[9 aa]:Peptide from inhA[9 aa] SO4 9 0 0 8 15 0 0 3 0 19 2 0 0 0 1 1 4 5 3 30 BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" ECO:0000269|PubMed:35705051, ECO:0007744|PDB:7P49, ECO:0007744|PDB:7P4B":BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="2" /ligand_note="self-peptide antigen":TOPO_DOM:/note="Extracellular":BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" ECO:0000269|PubMed:35705051, ECO:0007744|PDB:7P49, ECO:0007744|PDB:7P4B":BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="2" /ligand_note="self-peptide antigen":TOPO_DOM:/note="Extracellular" 181 L H b 0.0 7p4b_C 1 3 0 1 0 0 0 4 0 69 3 0 1 2 0 3 0 13 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 182 E H e 33.2 7p4b_C 2 0 20 30 0 1 2 0 9 6 3 7 1 2 4 6 3 1 0 3 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 183 D T e 59.9 7p4b_C TCA_HUMAN:NKG2A_HUMAN:TVA4_HUMAN:A0A075B6U7_HUMAN:TRAR1_HUMAN:TVAZ1_HUMAN:A0A087X096_HUMAN:TRAC_HUMAN:KK50.4 T cell receptor alpha chain[199 aa]:NKG2-A/NKG2-B type II integral membrane protein[11..:NKG2-A/NKG2-B type II integral membrane protein[12..:3H4 Fab light chain[214 aa]:TCR Gag:02-alpha,TCR Gag:02-alpha,TCR Gag:02-alpha..:T cell receptor alpha variable 26-1,T cell recepto..:T-cell receptor alpha chain[187 aa] 2 0 24 12 1 21 6 0 6 0 1 3 0 2 7 1 12 0 0 1 MUTAGEN:/note="D->A: Impairs the recognition by KLRD1-KLRC1.":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="D->A: Impairs the recognition by KLRD1-KLRC1.":TOPO_DOM:/note="Extracellular" 184 T H e 34.4 7p4b_C TCA_HUMAN:Q0QI92_HCMV:HLAG_HUMAN:INHA_MYCTU:TVA4_HUMAN:A0A075B6U7_HUMAN:TRAR1_HUMAN:TVAZ1_HUMAN:A0A087X096_HUMAN:TRAC_HUMAN:PPSB_MYCTU:ESXH_MYCTU:Peptide VMAPRTVLL[9 aa]:Peptide VTAPRTLLL[9 aa]:PEPTIDE (VMAPRTVLL)[9 aa]:VMAPRTLIL peptide from CMV gpUL40[9 aa]:KK50.4 T cell receptor alpha chain[199 aa]:Peptide from Glycoprotein[9 aa]:leader peptide of HLA class I histocompatibility a..:HLA class I histocompatibility antigen peptide[9 a..:Enoyl-[acyl-carrier-protein] reductase [NADH][9 aa..:ARG-GLN-PRO-ALA-LYS-ALA-PRO-LEU-LEU[9 aa]:ARG-LEU-PRO-ALA-LYS-ALA-PRO-LEU-PHE[9 aa]:ARG-MET-TYR-SER-PRO-THR-SER-ILE-LEU[9 aa]:Enoyl-[acyl-carrier-protein] reductase [NADH][12 a..:3H4 Fab heavy chain[225 aa]:VL9 leader peptide[9 aa]:3H4 Fab heavy chain[218 aa]:TCR Gag:02-alpha,TCR Gag:02-alpha,TCR Gag:02-alpha..:UL40(15-23 H4C)[9 aa]:T cell receptor alpha variable 26-1,T cell recepto..:T cell receptor alpha variable 4,T cell receptor a..:Phenolphthiocerol/phthiocerol polyketide synthase ..:ESAT-6-like protein EsxH[9 aa]:Peptide from inhA[9 aa] SO4 3 0 9 9 0 0 0 4 1 2 1 9 2 0 0 5 39 12 0 5 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 185 C H b 1.3 7p4b_C 0 85 2 0 1 2 0 0 0 0 0 0 0 0 3 0 0 0 2 1 DISULFID:ECO:0000269|PubMed:30087334, ECO:0000269|PubMed:35705051, ECO:0007744|PDB:7P49":TOPO_DOM:/note="Extracellular":DISULFID:ECO:0000269|PubMed:30087334, ECO:0000269|PubMed:35705051, ECO:0007744|PDB:7P49":TOPO_DOM:/note="Extracellular" 186 V H b 13.3 7p4b_C 4 3 1 1 1 1 0 5 4 5 1 2 40 1 1 1 11 14 0 4 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 187 E H e 48.7 7p4b_C 3H4 Fab light chain[214 aa]:T-cell receptor alpha chain[187 aa] SO4 9 0 2 25 1 5 3 1 1 3 0 1 1 15 20 6 2 1 0 3 MUTAGEN:/note="E->A: Reduces the affinity for KLRD1-KLRC1.":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="E->A: Reduces the affinity for KLRD1-KLRC1.":TOPO_DOM:/note="Extracellular" 188 W H e 20.7 7p4b_C Q0QI92_HCMV:HLAG_HUMAN:1C07_HUMAN:INHA_MYCTU:B6S6I4_9HIV1:PPSB_MYCTU:ESXH_MYCTU:Peptide VMAPRTVLL[9 aa]:Peptide VTAPRTLLL[9 aa]:PEPTIDE (VMAPRTVLL)[9 aa]:VMAPRTLIL peptide from CMV gpUL40[9 aa]:Peptide from Glycoprotein[9 aa]:leader peptide of HLA class I histocompatibility a..:HLA class I histocompatibility antigen peptide[9 a..:Mtb44*P2-Phe peptide variant (ARG-PHE-PRO-ALA-LYS-..:Enoyl-[acyl-carrier-protein] reductase [NADH][9 aa..:ARG-GLN-PRO-ALA-LYS-ALA-PRO-LEU-LEU[9 aa]:ARG-LEU-PRO-ALA-LYS-ALA-PRO-LEU-PHE[9 aa]:ARG-MET-TYR-SER-PRO-THR-SER-ILE-LEU[9 aa]:Enoyl-[acyl-carrier-protein] reductase [NADH][12 a..:3H4 Fab heavy chain[225 aa]:3H4 Fab light chain[214 aa]:VL9 leader peptide[9 aa]:3H4 Fab heavy chain[218 aa]:Gag6V[9 aa]:UL40(15-23 H4C)[9 aa]:Gag6V(276-284 H4C)[9 aa]:Phenolphthiocerol/phthiocerol polyketide synthase ..:ESAT-6-like protein EsxH[9 aa]:Peptide from inhA[9 aa] SO4 2 3 1 2 10 2 4 6 3 4 3 1 5 6 5 4 3 2 25 8 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 189 L H b 0.0 7p4b_C 2 1 0 0 3 1 0 2 5 50 0 5 0 0 16 8 0 5 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 190 H H e 47.1 7p4b_C 2 0 5 3 0 0 25 0 11 11 1 3 0 7 15 3 0 6 0 7 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 191 K H e 37.7 7p4b_C 3H4 Fab light chain[214 aa] 0 0 8 3 0 16 3 8 5 0 0 24 0 4 20 7 0 0 1 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 192 Y H b 1.7 7p4b_C Q0QI92_HCMV:HLAG_HUMAN:1C07_HUMAN:INHA_MYCTU:B6S6I4_9HIV1:PPSB_MYCTU:ESXH_MYCTU:Peptide VMAPRTVLL[9 aa]:Peptide VTAPRTLLL[9 aa]:PEPTIDE (VMAPRTVLL)[9 aa]:VMAPRTLIL peptide from CMV gpUL40[9 aa]:Peptide from Glycoprotein[9 aa]:leader peptide of HLA class I histocompatibility a..:HLA class I histocompatibility antigen peptide[9 a..:Mtb44*P2-Phe peptide variant (ARG-PHE-PRO-ALA-LYS-..:Enoyl-[acyl-carrier-protein] reductase [NADH][9 aa..:ARG-GLN-PRO-ALA-LYS-ALA-PRO-LEU-LEU[9 aa]:ARG-LEU-PRO-ALA-LYS-ALA-PRO-LEU-PHE[9 aa]:ARG-MET-TYR-SER-PRO-THR-SER-ILE-LEU[9 aa]:Enoyl-[acyl-carrier-protein] reductase [NADH][12 a..:VL9 leader peptide[9 aa]:Gag6V[9 aa]:UL40(15-23 H4C)[9 aa]:Gag6V(276-284 H4C)[9 aa]:Phenolphthiocerol/phthiocerol polyketide synthase ..:ESAT-6-like protein EsxH[9 aa]:Peptide from inhA[9 aa] 0 0 0 0 12 0 7 0 0 12 0 0 0 0 0 0 5 12 0 51 BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" ECO:0000269|PubMed:35705051, ECO:0007744|PDB:7P49":BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="2" /ligand_note="self-peptide antigen":TOPO_DOM:/note="Extracellular":BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" ECO:0000269|PubMed:35705051, ECO:0007744|PDB:7P49":BINDING:/ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="2" /ligand_note="self-peptide antigen":TOPO_DOM:/note="Extracellular" 193 L H b 7.9 7p4b_C 0 0 0 6 0 4 0 13 0 53 3 2 0 2 2 6 2 4 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 194 E H e 56.8 7p4b_C 5 0 5 30 3 6 0 3 8 4 5 2 5 7 1 6 1 8 0 3 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 195 K H e 31.1 7p4b_C 10 0 0 11 0 9 3 0 4 5 1 8 0 3 16 13 3 4 0 6 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 196 G T b 2.4 7p4b_C 6 0 0 5 3 44 0 5 0 7 4 0 3 3 9 8 0 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 197 K H e 46.7 7p4b_C 1 0 4 3 4 1 0 0 24 4 0 5 7 0 18 12 6 10 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 198 E H e 85.9 7p4b_C 6 0 4 23 7 7 0 1 4 3 4 7 5 7 2 12 6 1 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 199 T H e 53.2 7p4b_C GOL 5 0 5 6 0 3 3 2 2 5 1 4 7 0 2 7 35 10 0 2 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 200 L H b 1.7 7p4b_C GOL 12 0 1 1 12 1 0 12 1 12 0 0 12 12 1 1 12 12 0 0 TOPO_DOM:/note="Extracellular":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Extracellular" 201 L S e 50.6 7p4b_C 4 0 3 9 0 3 2 3 4 20 0 0 3 22 6 0 5 16 0 0 TOPO_DOM:/note="Extracellular":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Extracellular" 202 H e 52.4 7p4b_C ZN 0 2 3 0 0 4 7 0 4 0 0 10 2 7 32 0 17 7 3 0 TOPO_DOM:/note="Extracellular":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Extracellular" 203 L e 35.4 7p4b_C 5 0 0 0 2 0 5 7 6 10 0 3 7 8 10 2 20 12 0 0 TOPO_DOM:/note="Extracellular":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Extracellular" 204 E B e 38.2 7p4b_C ZN 4 0 10 19 2 6 3 0 0 3 2 0 9 8 6 7 0 15 0 5 TOPO_DOM:/note="Extracellular":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Extracellular" 205 P e 34.9 7p4b_C 4 4 0 4 4 0 4 0 5 0 0 0 44 5 5 5 8 8 0 0 TOPO_DOM:/note="Extracellular":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Extracellular" 206 P b 8.5 7p4b_C 1 0 1 15 1 1 0 1 15 1 0 1 15 1 1 15 15 15 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DISORDER:predicted by DISOPRED:DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 207 K E e 64.2 7p4b_C B2MG_HUMAN:Beta-2-microglobulin[98 aa] GOL 5 0 1 13 0 0 0 0 33 5 5 3 0 1 5 9 8 11 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DISORDER:predicted by DISOPRED:DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 208 T E e 26.6 7p4b_C 16 0 0 0 0 3 0 4 0 4 5 0 1 0 2 0 18 45 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DISORDER:predicted by DISOPRED:DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 209 H E e 40.8 7p4b_C 2 0 0 7 2 3 13 5 8 1 0 3 0 13 11 1 7 8 11 5 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 210 V E b 10.7 7p4b_C 2 0 0 0 2 0 0 8 0 21 2 0 0 2 0 0 5 55 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 211 T E e 21.4 7p4b_C B2MG_HUMAN:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[99 aa] 3 0 0 1 0 0 0 0 5 7 2 2 0 0 3 30 43 0 1 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 212 H E e 22.5 7p4b_C 5 4 0 3 4 6 15 1 5 6 0 6 2 7 17 13 0 4 0 2 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 213 H E e 38.2 7p4b_C B2MG_HUMAN:BETA-2-MICROGLOBULIN[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[97 aa]:Beta-2-microglobulin[99 aa] 0 0 0 3 3 8 27 0 6 2 0 0 3 8 14 17 4 1 0 3 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 214 P E e 72.9 7p4b_C 2 0 0 9 0 2 0 0 1 3 0 8 60 2 4 2 0 3 2 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 215 I e 53.8 7p4b_C 14 0 1 0 2 4 0 7 0 13 0 1 4 0 5 13 9 18 0 6 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 216 S S e 45.3 7p4b_C 6 0 0 11 4 7 0 0 6 7 0 10 17 2 1 24 3 0 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 217 D S e 93.8 7p4b_C ZN 1 0 16 11 0 12 2 1 1 6 2 11 13 3 4 10 5 4 0 1 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 218 H S e 77.0 7p4b_C ZN HLAE_HUMAN:HLA class I histocompatibility antigen, alpha chai.. 1 0 1 8 0 41 19 0 2 0 0 11 1 5 7 2 2 1 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 219 E E e 42.2 7p4b_C HLAE_HUMAN:HLA class I histocompatibility antigen, alpha chai.. 1 0 2 18 2 0 16 3 11 1 0 6 3 5 15 11 1 3 0 1 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 220 A E b 0.0 7p4b_C 23 0 1 0 0 0 0 5 1 11 0 16 7 1 5 6 7 17 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 221 T E b 11.0 7p4b_C 0 0 0 5 2 0 0 4 1 16 2 11 0 4 1 3 45 7 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 222 L E b 0.6 7p4b_C 3 0 0 0 3 0 0 2 0 81 0 0 0 0 0 0 0 10 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 223 R E b 18.2 7p4b_C B2MG_HUMAN:BETA-2-MICROGLOBULIN[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[97 aa]:Beta-2-microglobulin[99 aa] 4 0 0 0 6 0 1 9 4 2 0 9 0 0 17 1 22 26 0 1 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 224 C E b 0.0 7p4b_C 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DISULFID:ECO:0000269|PubMed:30087334, ECO:0000269|PubMed:35705051, ECO:0007744|PDB:7P49":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DISULFID:ECO:0000269|PubMed:30087334, ECO:0000269|PubMed:35705051, ECO:0007744|PDB:7P49":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 225 W E b 19.9 7p4b_C B2MG_HUMAN:BETA-2-MICROGLOBULIN[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[97 aa]:Beta-2-microglobulin[99 aa] GOL 3 0 0 0 8 0 15 0 1 15 2 0 0 5 15 14 3 0 11 8 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 226 A E b 0.0 7p4b_C 39 0 0 0 0 0 0 10 0 0 3 0 0 0 0 3 0 45 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 227 L E e 25.8 7p4b_C B2MG_HUMAN:BETA-2-MICROGLOBULIN[100 aa]:Beta-2-microglobulin[100 aa] EDO:GOL 1 0 9 1 10 0 3 2 2 14 0 8 0 0 2 26 9 0 2 9 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 228 G E b 8.3 7p4b_C GOL 0 0 20 0 0 51 0 0 6 0 0 13 0 0 3 7 0 0 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 229 F E b 0.0 7p4b_C 0 0 0 0 86 0 0 6 0 6 0 0 0 0 0 0 0 0 0 1 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 230 Y B b 6.5 7p4b_C GOL 0 1 0 0 12 0 11 0 0 0 0 0 0 0 0 7 1 0 0 69 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 231 P S b 14.0 7p4b_C EDO 0 0 0 0 0 0 0 0 0 0 0 0 96 0 0 2 2 0 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 232 A S b 17.9 7p4b_C GOL 19 0 0 4 0 16 0 0 10 1 0 0 25 8 10 4 2 0 1 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 233 E e 60.8 7p4b_C 1 0 15 21 0 0 2 3 4 0 0 8 12 8 7 6 1 12 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 234 I b 8.8 7p4b_C 4 0 0 0 0 2 0 58 0 12 0 0 0 0 0 0 0 24 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 235 T E e 44.8 7p4b_C SO4 0 0 2 9 4 1 0 0 10 0 0 12 0 8 0 10 32 1 9 1 MUTAGEN:/note="T->A: Has no impact on the affinity for KLRD1- KLRC1.":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="T->A: Has no impact on the affinity for KLRD1- KLRC1.":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 236 L E b 3.9 7p4b_C 0 0 0 0 2 0 0 20 0 29 5 0 0 0 0 0 0 44 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 237 T E b 19.5 7p4b_C SO4 2 0 3 4 0 0 5 2 3 2 9 2 0 5 18 4 40 1 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 238 W E b 0.0 7p4b_C 0 0 0 0 8 0 0 0 0 9 0 0 0 0 0 0 0 0 84 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 239 Q E e 30.6 7p4b_C SO4 0 0 0 2 11 0 0 3 6 36 17 3 0 14 3 2 2 0 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 240 Q E e 31.1 7p4b_C HLAE_HUMAN:HLA class I histocompatibility antigen, alpha chai.. SO4 6 1 0 4 0 0 4 0 26 6 0 0 0 14 38 2 0 0 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 241 D T e 47.5 7p4b_C 5 0 28 2 0 3 0 0 0 1 0 46 1 0 4 1 0 1 0 5 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 242 G T e 98.8 7p4b_C 0 0 1 1 0 84 0 0 1 0 0 3 0 0 4 5 0 0 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 243 E B e 49.7 7p4b_C 4 0 4 28 0 0 2 0 24 2 0 7 0 18 1 1 4 4 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 244 G S e 41.7 7p4b_C 8 0 7 16 0 3 0 1 10 6 1 0 19 11 1 8 2 5 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 245 H S e 68.1 7p4b_C HLAE_HUMAN:HLA class I histocompatibility antigen, alpha chai.. 2 0 2 23 1 3 3 6 3 15 3 0 0 8 2 7 2 20 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 246 T b 6.5 7p4b_C SO4 8 0 0 5 1 4 0 4 6 1 6 0 4 13 4 9 30 5 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 247 Q T e 79.6 7p4b_C HLAE_HUMAN:HLA class I histocompatibility antigen, alpha chai.. 6 0 5 17 2 2 2 1 3 2 0 1 8 33 1 7 6 5 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 248 D T e 84.6 7p4b_C B2MG_HUMAN:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[100 aa] HLAE_HUMAN:HLA class I histocompatibility antigen, alpha chai.. 0 0 27 19 0 33 2 0 8 0 0 3 0 1 2 4 1 0 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 249 T e 25.3 7p4b_C 7 0 0 0 2 3 0 1 0 1 6 2 4 0 2 10 34 27 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 250 E E e 57.3 7p4b_C 3 0 8 32 7 6 3 0 2 0 0 2 1 10 2 14 0 6 1 2 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 251 L E e 48.3 7p4b_C 5 4 0 8 3 3 2 2 3 17 5 2 6 8 8 10 5 5 0 4 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 252 V e 21.3 7p4b_C B2MG_HUMAN:BETA-2-MICROGLOBULIN[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[97 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[99 aa] GOL 1 2 0 3 0 21 1 2 2 2 1 5 6 0 1 13 21 16 0 2 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 253 E e 87.4 7p4b_C B2MG_HUMAN:BETA-2-MICROGLOBULIN[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[97 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[99 aa] SO4 3 0 25 15 1 11 0 0 7 3 2 2 5 5 1 12 3 5 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 254 T e 33.8 7p4b_C B2MG_HUMAN:Beta-2-microglobulin[100 aa] SO4:GOL 0 0 0 0 9 0 1 12 0 15 1 7 9 0 0 0 29 14 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 255 R E e 35.6 7p4b_C B2MG_HUMAN:BETA-2-MICROGLOBULIN[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[97 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[99 aa] EDO:GOL 0 0 0 5 4 6 1 8 3 35 1 0 0 2 15 9 7 2 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 256 P E e 76.7 7p4b_C B2MG_HUMAN:BETA-2-MICROGLOBULIN[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[97 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[99 aa] GOL 1 2 1 1 7 1 1 1 4 3 0 0 63 3 6 3 1 2 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 257 A e 36.6 7p4b_C B2MG_HUMAN:BETA-2-MICROGLOBULIN[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[97 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[99 aa] 13 0 2 1 0 3 2 2 3 1 0 35 0 7 4 20 4 3 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 258 G S e 88.1 7p4b_C B2MG_HUMAN:BETA-2-MICROGLOBULIN[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[97 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[99 aa] 15 0 3 2 2 49 0 0 7 2 0 3 1 0 1 9 3 2 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 259 D S e 73.5 7p4b_C B2MG_HUMAN:BETA-2-MICROGLOBULIN[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[97 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[99 aa] GOL 0 0 80 0 0 0 0 0 0 0 0 14 4 3 0 0 0 0 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 260 G S e 60.7 7p4b_C GOL 0 0 1 3 0 52 7 0 0 1 0 3 0 0 3 3 0 0 24 3 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 261 T b 14.3 7p4b_C GOL 0 0 0 0 0 0 0 0 3 5 0 3 0 0 2 17 71 0 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 262 F E b 15.3 7p4b_C GOL 0 0 0 0 51 0 0 0 0 0 0 3 0 0 0 0 0 0 10 36 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 263 Q E e 25.5 7p4b_C B2MG_HUMAN:BETA-2-MICROGLOBULIN[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[97 aa]:Beta-2-microglobulin[98 aa]:Beta-2-microglobulin[99 aa] EDO:GOL 3 0 0 0 7 0 13 0 3 4 0 6 0 43 2 5 0 0 0 14 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 264 K E b 14.2 7p4b_C SO4 13 0 0 0 0 3 0 6 22 17 1 0 0 5 5 7 16 3 0 4 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 265 W E b 10.4 7p4b_C B2MG_HUMAN:BETA-2-MICROGLOBULIN[100 aa]:Beta-2-microglobulin[100 aa]:Beta-2-microglobulin[97 aa]:Beta-2-microglobulin[99 aa] GOL 3 0 0 0 4 3 4 3 0 21 1 0 0 2 9 4 6 2 36 2 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 266 A E b 0.0 7p4b_C 24 3 0 1 0 0 3 1 0 4 2 2 0 0 0 24 0 36 0 1 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 267 A E b 1.8 7p4b_C 12 0 0 3 3 0 5 2 2 5 12 0 0 0 2 18 16 2 1 16 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 268 V E b 2.0 7p4b_C 6 0 0 0 3 0 0 8 0 52 0 0 0 0 0 3 5 21 0 1 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 269 V E e 47.3 7p4b_C 11 0 11 23 0 1 1 0 0 5 0 3 3 0 6 2 16 12 2 3 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 270 V E b 0.0 7p4b_C 1 0 0 0 16 0 0 8 0 12 7 0 0 0 0 0 4 52 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 271 P E e 32.6 7p4b_C HLAE_HUMAN:HLA class I histocompatibility antigen, alpha chai.. 9 1 4 1 4 0 0 3 4 13 0 3 23 1 1 8 17 7 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 272 S T e 40.6 7p4b_C 16 3 0 0 0 0 0 0 0 8 0 1 48 3 2 16 3 0 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 273 G T e 84.5 7p4b_C 0 0 0 6 0 39 1 0 1 0 0 5 0 13 9 19 4 0 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 274 E e 36.7 7p4b_C HLAE_HUMAN:HLA class I histocompatibility antigen, alpha chai.. 3 0 18 30 0 1 1 0 4 1 0 4 4 11 4 10 3 3 0 2 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 275 E G b 10.1 7p4b_C 9 0 11 37 0 16 0 2 2 0 0 7 1 3 2 3 3 0 3 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 276 Q G e 39.8 7p4b_C 11 0 24 10 0 0 7 0 4 0 0 1 5 24 0 5 3 5 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 277 R G e 45.8 7p4b_C HLAE_HUMAN:HLA class I histocompatibility antigen, alpha chai.. 0 0 1 4 3 12 4 6 4 1 0 6 5 8 14 6 4 19 0 1 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 278 Y E b 3.9 7p4b_C HLAE_HUMAN:HLA class I histocompatibility antigen, alpha chai.. 0 0 0 0 21 0 0 0 0 13 0 0 0 0 0 0 0 0 0 66 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 279 T E b 13.6 7p4b_C 5 1 9 1 2 0 0 0 0 0 0 0 0 3 1 25 51 2 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 280 C E b 0.0 7p4b_C 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DISULFID:ECO:0000269|PubMed:30087334, ECO:0000269|PubMed:35705051, ECO:0007744|PDB:7P49":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DISULFID:ECO:0000269|PubMed:30087334, ECO:0000269|PubMed:35705051, ECO:0007744|PDB:7P49":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 281 H E e 29.3 7p4b_C 0 0 0 2 0 0 19 1 10 3 0 6 0 24 24 2 0 7 1 2 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 282 V E b 0.0 7p4b_C 0 0 0 0 0 0 0 3 0 6 3 0 0 0 0 0 0 88 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 283 Q E e 47.4 7p4b_C 2 0 5 38 0 2 0 0 11 0 5 1 0 12 5 6 9 1 0 2 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 284 H b 2.1 7p4b_C 0 0 0 0 0 0 98 0 0 0 0 0 0 0 0 0 0 0 0 2 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 285 E T e 59.8 7p4b_C EDO 3 2 5 27 0 1 3 1 2 1 0 0 13 3 3 19 4 3 10 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 286 G T e 21.4 7p4b_C 8 1 0 0 0 53 0 0 0 0 0 0 0 2 0 28 8 0 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 287 L S b 14.6 7p4b_C 1 0 0 0 3 0 0 0 0 77 1 0 2 5 0 0 1 7 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 288 P S e 94.6 7p4b_C 8 0 18 9 0 4 1 0 7 2 1 1 26 6 0 7 8 0 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 289 E S e 64.3 7p4b_C 2 0 3 27 0 0 3 0 9 1 2 3 0 32 3 11 2 0 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 290 P e 54.3 7p4b_C 1 0 12 0 0 0 1 0 0 0 3 0 68 2 2 6 0 2 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 291 V E e 30.0 7p4b_C 0 0 0 0 1 2 0 23 6 42 3 0 0 2 1 0 0 17 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 292 T E e 56.5 7p4b_C 0 0 0 0 0 0 0 15 0 15 1 0 0 2 4 7 42 12 0 0 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 293 L E b 7.3 7p4b_C 3 0 0 5 0 3 0 0 11 28 0 0 0 2 3 0 0 40 0 4 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 294 R e 42.7 7p4b_C 0 0 5 19 0 0 11 2 12 1 0 0 2 6 21 5 2 0 0 12 DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C1-type":TOPO_DOM:/note="Extracellular" 295 W e 25.1 7p4b_C 2 0 0 0 0 2 0 0 0 8 0 0 0 2 0 0 5 0 77 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 296 K e 68.9 7p4b_C 2 0 14 39 2 5 1 0 12 3 0 1 2 0 12 1 3 3 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 297 P e 100.0 7p4b_C 18 0 0 3 1 1 3 0 0 3 0 1 51 5 1 10 0 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 298 A 6 3 0 8 0 4 3 2 3 6 0 0 13 17 7 18 9 0 1 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 299 S 5 0 0 6 2 9 0 0 0 7 0 5 8 8 1 41 5 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 300 Q 2 0 4 18 0 4 2 3 14 4 3 4 4 11 3 20 4 0 0 1 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 301 P 2 0 1 4 0 8 0 2 1 5 3 6 32 3 1 16 12 3 0 2 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 302 T 13 0 5 3 1 4 0 2 1 9 3 2 0 0 0 13 27 14 1 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 303 I 1 0 1 1 2 4 0 23 4 15 5 0 0 7 5 5 3 21 3 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 304 P 1 8 1 1 1 10 0 7 4 8 2 2 24 1 1 13 5 5 0 7 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 305 I 10 0 0 0 0 1 3 25 1 22 2 8 0 0 2 3 3 17 0 1 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 306 V 6 0 0 0 0 12 0 8 2 19 5 0 0 0 0 2 3 39 0 1 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 307 G 8 0 0 3 0 52 0 5 2 3 0 2 3 0 1 10 0 9 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 308 I 3 4 3 0 6 2 0 35 2 22 0 5 0 0 0 2 5 10 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 309 I 7 0 0 0 1 1 0 38 0 5 1 0 0 0 0 8 1 39 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 310 A 22 0 0 8 1 6 0 3 0 16 0 0 0 0 0 16 4 24 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 311 G 9 4 1 0 4 56 0 6 5 3 0 0 3 0 0 1 0 9 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 312 L 9 0 0 0 4 1 0 7 0 43 0 0 0 0 5 2 15 13 1 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 313 V 11 1 0 0 5 1 0 27 0 13 1 0 0 0 0 0 5 35 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 314 L 1 2 1 0 14 7 0 11 0 29 1 0 0 0 0 1 4 25 0 2 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 315 L 3 3 0 1 6 3 0 15 0 52 0 0 0 0 0 1 0 13 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 316 G 18 0 1 1 2 25 0 7 1 5 5 5 4 1 1 1 1 19 0 1 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 317 S 18 5 1 1 9 6 0 11 1 16 0 6 1 1 1 5 4 13 0 1 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 318 V 9 0 1 1 4 1 0 26 1 14 1 1 1 1 1 1 6 30 0 1 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 319 V 5 0 1 1 5 1 0 29 1 18 4 1 1 1 1 1 4 27 0 1 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 320 S 17 6 1 1 8 2 0 7 1 8 0 1 3 1 1 13 12 17 0 1 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 321 G 5 2 1 1 0 66 0 4 1 5 0 5 1 0 1 5 1 3 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 322 A 34 0 1 6 3 10 0 16 1 9 1 1 1 1 1 3 5 5 0 1 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 323 V 2 8 1 1 1 6 0 14 6 2 2 1 1 1 1 2 1 48 0 1 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 324 V 3 0 1 1 4 3 0 9 1 19 2 0 0 0 0 1 6 49 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 325 A 27 0 1 1 6 38 0 6 1 6 0 1 1 1 1 1 4 5 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 326 A 26 0 1 1 13 3 0 6 1 18 0 0 1 0 2 1 9 13 0 4 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 327 V 1 0 0 0 9 1 0 17 4 17 4 0 0 0 0 1 0 35 6 4 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 328 I 1 0 0 0 8 4 0 29 0 22 20 0 0 0 6 3 0 3 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 329 W 0 7 0 0 0 0 0 8 4 0 6 1 0 0 13 0 0 4 49 5 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 330 R 0 0 0 0 5 2 6 0 8 0 4 2 0 8 64 0 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 331 K 0 0 0 0 0 8 0 0 26 0 0 0 0 6 60 0 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 332 K 0 0 0 0 0 0 4 0 25 9 7 3 6 5 30 7 0 0 6 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 333 S 4 0 0 0 0 2 4 0 0 0 0 15 6 7 20 37 0 2 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 334 S 13 0 0 0 0 0 0 1 10 0 0 2 0 0 9 50 15 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 335 G 5 0 8 7 0 65 0 0 3 0 0 0 0 0 5 7 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 336 G 0 0 0 9 0 56 4 0 7 0 0 0 10 5 6 0 0 5 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 337 K 6 0 0 0 0 0 0 0 46 0 0 9 0 8 12 5 7 8 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 338 G 0 0 0 4 0 67 0 0 0 0 13 0 0 0 15 0 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 339 G 5 0 3 0 0 76 0 0 6 0 0 0 2 0 3 0 0 6 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 340 S 0 1 23 0 0 12 4 2 0 0 5 3 0 0 11 33 0 5 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 341 Y 0 5 0 0 0 0 0 0 0 0 0 3 0 0 0 0 0 10 0 81 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 342 S 15 0 0 0 0 0 0 2 11 0 0 8 0 8 0 29 11 16 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 343 K 4 0 0 0 0 0 4 8 15 30 0 0 12 28 0 0 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 344 A 71 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11 16 2 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 345 E 29 0 0 21 0 0 0 0 0 14 0 0 25 8 0 2 0 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 346 W 0 8 0 0 0 33 0 0 0 0 0 0 0 0 7 20 0 12 20 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 347 S 0 0 3 0 0 2 0 0 0 0 0 12 0 0 3 65 15 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 348 D 0 0 40 13 0 0 3 0 3 0 0 21 0 20 0 0 0 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 349 S 0 0 0 0 0 13 0 0 0 0 0 0 12 0 3 63 9 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 350 A 58 0 3 0 3 0 0 0 0 0 0 0 0 0 0 36 0 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 351 Q 0 0 13 8 0 0 0 0 0 0 0 0 0 62 0 17 0 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 352 G 0 0 0 0 0 54 0 0 0 9 13 0 17 0 0 4 3 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 353 S 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 MOD_RES:/note="Phosphoserine":COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":MOD_RES:/note="Phosphoserine":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 354 E 0 0 92 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 355 S 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 356 H 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 357 S 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 358 L 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic"